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Resumo  
Considerando a importância dos peixes G. rufa para a aquacultura, comércio de aquários 
ornamentais, indústria dos spa e o turismo termal, sendo o seu bem-estar uma questão 
ética importante. A anestesia pode ser necessária para minimizar o sofrimento dos animais 
e sem comprometer o bem-estar dos mesmos, durante os procedimentos de rotina ou 
mesmo na administração de um tratamento em aquacultura. O presente trabalho verificou 
a viabilidade do uso do MS-222, 2-fenoxietanol e óleo de cravinho em Garra rufa (Heckel, 
1843) para esse fim, determinou-se também a concentração efetiva mínima de acordo com 
o tamanho do corpo do peixe. Portanto, três classes de tamanho de Garra rufa (peixes 
pequenos, médios e grandes) foram submetidas a oito concentrações diferentes de  
MS-222 (225 a 400 mg L-1, com incrementos de 25 mg L-1), seis concentrações de  
2 -fenoxietanol (525 a 900 mg L-1, com incrementos de 75 mg L-1) e quatro concentrações 
de óleo de cravinho (110 a 170 mg L-1, com incrementos de 20 mg L-1). Os tempos de 
indução, monitorização e recuperação da anestesia (além de seus respectivos estádios) 
foram registrados para cada peixe. Durante a fase de monitorização, G. rufa foi medido 
quanto ao comprimento total, pesado, observado para determinação do sexo e também se 
verificou a ausência de movimentos operculares / contrações musculares, para avaliar a 
anestesia. Posteriormente, foi avaliado o apetite imediato por alimento e os peixes foram 
monitorados durante uma semana quanto à ocorrência de mortalidade ou lesão. Todos os 
peixes recuperaram rápido e bem, sem sequelas visíveis ou mortalidade. Todos os peixes 
eram do sexo masculino e apresentaram apetite pela comida após anestesia, ingerindo a 
dose diária total de ração. Quanto aos tempos de indução, monitorização e recuperação, 
variaram de acordo com o anestésico, concentração e tamanho do peixe. O óleo de 
cravinho foi o que apresentou os maiores tempos de indução e recuperação, enquanto o 
MS-222 e o 2-fenoxietanol apresentaram resultados semelhantes. Recomenda-se que, 
para 29 °C, uma concentração de 300 mg L-1 de MS-222 seja usada em peixes pequenos 
(4,31 ± 0,42 cm e 0,86 ± 0,70 g), enquanto em peixes médios (6,46 ± 0,85 cm e 3,20 ± 1,62 
g) deve ser de 350 mg L-1 e 375 mg L-1 para peixes de tamanho grande (9,42 ± 0,70 cm e 
9,74 ± 1,97 g). Em relação ao 2-fenoxietanol, 750 mg L-1 para peixes de tamanho grande 
(9,30 ± 0,67 cm e 10,0 ± 2,06 g) e 825 mg L-1 para peixes pequenos (4,53 ± 0,32 cm e 0,75 
± 0,26 g) e peixes médios (6,44 ± 0,90 cm e 3,29 ± 1,62 g).  
Da mesma forma, a dose recomendada de óleo de cravinho para G. rufa a 29 ° C é de 130 
mg L-1 para todas as classes de tamanho (4,41 ± 0,26 cm e 0,69 ± 0,19 g para os pequenos, 
6,48 ± 0,89 cm e 3,15 ± 1,36 g para os médios e 9,43 ± 0,54 cm e 9,86 ± 1,84 g para os 
grandes), embora 150 mg L-1 também funcionasse bem.  
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Estas concentrações eram geralmente mais altas do que as descritas para outras espécies 
de peixes, mesmo aquelas com temperatura da água, tamanho corporal e filogenia 
semelhantes. 
Palavras-chave: Anestesico, Tempo de Indução, Tempo de Monitorização, Tempo de 
Recuperação, Aquicultura, Ictoterapia, Bem-Estar, Ciprinídeo, Dose, Concentração. 
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Abstract  
Considering the importance of G. rufa fish for aquaculture, ornamental aquarium trade, spa 
industry and thermal tourism, its welfare is an important ethical issue. Anaesthesia may be 
required to minimize animal suffering and reinforce its well-being, during aquaculture routine 
procedures or even, treatment administration. The present work verified the viability of using 
MS-222, 2-phenoxyethanol and clove oil in Garra rufa (Heckel, 1843) for that purpose, 
determined also their minimum effective concentration according to fish’s body size. 
Therefore, three size classes of G. rufa (small, medium and large fish) were subjected to 
eight different concentrations of MS-222 (225 to 400 mg L-1, with increments of 25 mg L-1), 
six concentrations of 2-phenoxyethanol (525 to 900 mg L-1, with increments of 75 mg L-1) 
and four concentrations of clove oil (110 to 170 mg L-1, with increments of 20 mg L-1). The 
times for anaesthesia induction, monitoring and recovery phases (plus of their respective 
stages) were recorded for each fish. During the monitoring phase, G. rufa were measured 
for total length, weighted, observed to determine the gender and verify the absence of 
opercular movements/muscle contractions, as to assess anaesthesia. Afterwards, the 
immediate appetence for food was evaluated and the fish were monitored during a week 
for the occurrence of mortality or injury. All fish recovered fast and well, without visible 
sequels or mortality. All fish were males and presented appetence for food after 
anaesthesia, ingesting the total daily dose of feed. Regarding the induction, monitoring and 
recovery times, they varied according to the anaesthetic, concentration and fish size class. 
Clove oil was the one with the longest induction and recovery times, while MS-222 and 2-
phenoxyethanol presented similar results. It is recommended that for 29 °C, a MS-222 
concentration of 300 mg L-1 should be used in small fish (4.31 ± 0.42 cm and 0.86 ± 0.70 g) 
whilst for the medium fish (6.46 ± 0.85 cm and 3.20 ± 1.62 g) should be 350 mg L-1 and 
375 mg L-1 for the large size fish (9.42 ± 0.70 cm and 9.74 ± 1.97 g). In regard to 2-
phenoxyethanol, it is 750 mg L-1 for the large fish (9.30 ± 0.67 cm and 10.0 ± 2.06 g) and 
825 mg L-1 for the small (4.53 ± 0.32 cm and 0.75 ± 0.26 g) and medium fish (6.44 ± 0.90 
cm and 3.29 ± 1.62 g). Likewise, the recommended dose of clove oil for G. rufa at 29 °C is 
130 mg L-1 for all size classes (4.41 ± 0.26 cm and 0.69 ± 0.19 g for the small, 6.48 ± 0.89 
cm and 3.15 ± 1.36 g for the medium and 9.43 ± 0.54 cm and 9.86 ± 1.84 g for the large) 
even though 150 mg L-1 worked good as well. These concentrations were usually higher 
than the ones described for other fish species, even those with similar water temperature, 
body size and phylogeny. 
Keywords: Anaesthetic, Induction Time, Monitoring Time, Recovery Time, Aquaculture, 
Ichthyotherapy, Welfare, Cyprinid, Dose, Concentration 
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1. Introduction 
1.1 - Anaesthesia 
The word anaesthesia comes from a Greek derivation, of the words an – “without” and  
aisthesis – “sensation” which combined mean loss of sensitivity (Ross & Ross, 2008; Zahl 
et al., 2012). This theme covers several components such as sedation, immobilisation, 
unconsciousness (narcosis), amnesia (loss of memory) and analgesia (pain relief) (Zahl et 
al., 2011). According to Zahl et al. (2012) sedation is a reduction in sensitivity, which results 
in tranquillity and calmness. Narcosis (general anaesthesia) causes a state of 
unconsciousness and amnesia including also immobilisation and pain relief (analgesia). 
Generally speaking, anaesthesia is characterized by a specific acting on the peripheral 
and/or central nervous system in which occurs a suppression of the ation potencial of the 
nerve cells, through the release of inhibitory neurotransmitters or by the change in plasma 
membrane permeability, or even a combination of these two elements (Ross & Ross, 2008). 
Fish have a basic neural system that confers them the perception of painful stimuli, namely 
nociception. This has been verified and demonstrated in studies with rainbow trout 
(Oncorhynchus mykiss) (Walbaum, 1792) and goldfish (Carassius auratus) (Linnaeus, 
1758) (Sneddon 2002, 2003; Sneddon et al., 2003; Dunlop & Laming 2005). When applying 
procedures that can inflict harm or pain, minimising animal suffering is essential, which is 
why it is necessary to use anaesthetics with the ability to block nociceptive pathways. 
Benzocaine, isoeugenol and MS-222 are substances known to have this ability (Zahl et al., 
2012). 
In many parts of the world and for various species of fish, anaesthesia has been used in 
many processes and procedures, involving their maintenance in aquaculture (Wagner et 
al., 2002; Coyle et al., 2004; Purbosari et al., 2019). These processes (such as handling, 
vaccination, transportation, surgery, assessment of health and physical conditions, plus 
others) can cause long periods of stress, creating negative impacts on the growth, 
reproduction, health, and survival of fish (Wagner et al., 2002; Iveresen et al., 2003; Mylonas 
et al., 2005; Ross & Ross 2008; Weber et al., 2009; Perdikaris et al., 2010; Heo & Shin, 
2010; Javahery et al., 2012). 
Using anaesthesia makes these processes easier, minimizing the risks of handling and 
alleviating the stress (Ross & Ross 2008; Perdikaris et al., 2010). 
The selection of anaesthetics to be used in fish must be made to taking into account the 
following factors: fast effect on the immobilisation of fish good recovery rates, no toxicity or 
low levels of hazardousness for the fish, staff and the environment, easiness to administer, 
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low cost, availability and legislation (Marking & Meyer, 1985; Gilderhus & Marking, 1987; 
Soto & Burhanuddin, 1995; Burka et al., 1997; Cho & Heath, 2000; TrevesBrown, 2000). 
According to Burka et al. (1997) and Ross & Ross, (1999) the efficacy of anaesthetics is 
conditioned by environmental (e.g.: pH, temperature, salinity) and biological factors, such 
as fish species, individual weight, size, gender, sexual maturity, body condition and 
composition (e.g: lipid content), health status, and stress.  
 
1.2 - Application of anaesthesia  
Anaesthetic agents used for general anaesthesia are usually combined with analgesic 
agents that target nociception (Zahl et al., 2012). Resistance and tolerance to anaesthetic 
action are known to vary between closer phylogenetic species, but also from species to 
species and even in between individuals of the same species (Hikasa et al., 1986). Given 
this situation, each fish species reacts differenty to various concentrations from the same 
anaesthetic. So determining the most effective minimum anaesthetic concentrations is very 
important issue (Pawar et al., 2011).  
The effect of anaesthesia is usually assessed by the time of induction and recovery, reflex 
reactions to external stimuli and the responsiveness to handling (Zahl et al., 2012). 
Frequently, the higher the concentration used, the shorter will be the anaesthetia induction 
time. Conversely, there is also an inverse relationship between the induction and  the 
recovery times (Park et al., 2008). Anaesthesia can also be affected by water temperature 
(Walsh & Pease, 2002), fish size and gender (Woody et al., 2002). Moreover, an anaesthetic 
should not produce any lasting physiological effects, for which it should be rapidly excreted 
from the body and must show high water solubility, regardless of its salinity (Ross & Ross, 
1999, 2008; Coyle et al., 2004). 
 
1.3 - States of anaesthesia 
Exposure of fish to different anaesthetics causes different responses. These responses are 
influenced according to the species under study, the concentrations used, environmental 
factors (e. g.: temperature and pH) and biological factors (Summerfelt & Smith 1990; Coyle 
et al., 2004). Anaesthesia ranges from light sedation - to reduce stress during handling and 
non-invasive procedures to general anaesthesia - used to avoid inflicting pain during 
surgeries and other invasive procedures (Summerfelt & Smith 1990; Ross & Ross, 2008; 
Neiffer & Stamper, 2009; Zahl et al., 2012). To assess the progress of induction and depth 
of anaesthesia, different stages are evaluted. To determine these stages during 
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anaesthesia of animals, clinical indicators such as behaviour, activity, corneal reflexes and 
pupil size, muscle tone, reflexes, respiratory rate, heart rate and blood pressure are chosen. 
Some of these indicators are difficult to assess in fish, so others may be used used instead, 
which are mostly based on swimming activity changes, buoyancy balance, respiratory rate 
and reactions to external stimuli (Zahl et al., 2012), as the ones demonstrated in Table I. 
Table I – Stages of anaesthesia in fish by Akinrotimi et al. (2015). 
 
1.4 - Anaesthesia methods  
Immersion anaesthesia is the most commonly used methodology for the administration of 
anaesthetics in aquaculture and consists of dissolving an amount of the anaesthetic agent 
in water to obtain the desired concentration (Coyle et al., 2004; Ross & Ross, 2008; Neiffer 
& Stamper, 2009). Immersion anaesthetics may be water-soluble or insoluble. The insoluble 
ones are first dissolved in an organic solvent and then diluted in water (Neiffer & Stamper, 
2009). 
For simple and short-term procedures, the anaesthetic solution is prepared in an aerated 
container, filled with water from the fish rearing system (Coyle et al., 2004; Ross & Ross, 
2008; Neiffer & Stamper, 2009). This water should be changed frequently to ensure the 
desired anaesthetic concentration (Ross & Ross, 2008; Neiffer & Stamper, 2009). The fish 
is immersed in the anaesthetic solution until reaching the pretended anaesthesia stage. 
Afterwards, the fish can be handled or intervened and then transferred to a clean water 
container, where it will be let to recover. The water used in the recovery container should 
also be originally from the animals rearing system as well (Ross & Ross, 2008; Neiffer & 
Stamper, 2009).  
Stage of Anaesthesia Description 
Induction I Slow swimming 
 II Slight increase in opercula beat frequency 
 III Loss of equilibrium 
 IV Loss of reflexes and movement 
 V Deep anaesthesia, fish lies on one side 
Recovery I Reappearance of opercula movement 
 II Partial recovery of equilibrium 
 III Irregular balance 
 IV Total recovery of equilibrium 
 V Normal swimming 
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During the recovery phase, water should also be renewed frequently to avoid reabsorption 
of metabolites excreted by anesthetized fish (Ross & Ross, 2008; Neiffer & Stamper, 2009). 
The immersion anaesthetics are generally absorbed through the gills, via inhalation as route 
of administration. While the fish ventilates in the anaesthetic solution, the anaesthetic agent 
contacts with gills and diffuses into the bloodstream, rapidly reaching the nervous system 
(Summerfelt & Smith 1990; Ross & Ross, 2008; Neiffer & Stamper, 2009). Nevertheless, 
many anaesthetics may also be absorbed through the skin of fish (scalless or with few or 
thin scales). The efficiency of absorption by immersion in gill tissue and skin is directly 
related to the lipid solubility of the anaesthetic used, as the composition of these organs 
surfaces contain large amounts of lipids (Neiffer & Stamper, 2009). Afterwards, when the 
fish is put back into water without anaesthetic, it excretes the agent (or its metabolites) 
through the gills, kidneys and skin (Ross & Ross, 1999, 2008; Walsh & Pease, 2002). 
Futhermore, there are also anaesthetics that can be administered orally, intravenously and 
intramuscularly (Ross & Ross, 2008; Neiffer & Stamper, 2009). Oral anaesthesia is used 
less frequently, because there are few studies on oral anaesthetics. Even more, the 
anaesthetic needs to be incorporated into the fish diet, which makes it difficult to apply the 
exact dose needed to be administered. The rate and degree of absorption are uncertain, as 
there are no guarantees that the anaesthetic is evenly distributed in the diet (Ross & Ross, 
2008; Neiffer & Stamper, 2009), if part of the anesthetic is dissolved and lost in the water, 
or even if the fish eat the all dose of anaesthetic. This technique is not practical and is not 
commonly used in aquaculture routines, but can be used in medical or research laboratories 
(Neiffer & Stamper, 2009). 
 
1.5 - Anaesthetics  
There are two types of anaesthetics: non-chemical and chemical (Ross & Ross, 2008; 
Neiffer & Stamper, 2009). Non-chemical anaesthetics are not used as often but are still a 
possibility in aquaculture, such as electro-anaesthesia and hypothermia (Coyle et al., 2004; 
Ross & Ross, 2008).The chemical  anaesthesics are the most commonly used anaesthetics 
in aquaculture, namely MS-222 (tricaine methane sulphonate), 2-phenoxyethanol (ethylene 
glycol monophenyl ether), clove oil, benzocaine (ethyl-paminobenzoate), etomidate, 
quinaldine, and quinaldine sulphate (Neiffer & Stamper, 2009; Ross & Ross 2008; Mylonas 
et al., 2005; Perdikaris et al., 2010; Mercy et al., 2013; Carter et al., 2011). 
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1.5.1 – Tricaine methane sulphonate 
The anaesthetic tricaine methane sulphonate (C9H11O2N + CH3SO3H) is also referred to as 
MS-222 and is one of the most widely used anaesthetics in poikilotherm organisms 
worldwide with fast induction and recovery times (Hunn & Allen, 1974; Ross & Ross, 2008; 
Popovic et al., 2012; Priborsky & Velisek, 2018). 
MS-222 is the only one to be approved in the United States by the Food and Drug 
Administration (FDA) (Coyle et al., 2004; Carter et al., 2011). In Europe, this anaesthetic is 
licensed by the European Medicines Agency (EMA) to be used on fish but under specific 
circumstances, depending on each country legislation (Popovic et al., 2012; Priborsky & 
Velisek, 2018).  
Tricaine methane sulphonate is an odourless white crystalline powder with high water 
solubility (1 g L-1 at 20 °C). Is generally used in the immersion anaesthesia method 
(Priborsky & Velisek, 2018). MS-222 anaesthesia becomes more effective and at the same 
time, safer for fish when it is neutralized (Neiffer & Stamper, 2009; Priborsky & Velisek, 
2018). MS-222 causes drastic changes in pH, acidifying the water, especially in freshwater, 
whose buffering capacity is lower than the one of saltwater (Ross & Ross, 2008; Neiffer & 
Stamper, 2009; Priborsky & Velisek, 2018). Therefore, sodium bicarbonate is generally 
added to buffer the anaesthetic solution, ajusting pH in accordance with fish welfare. 
Usually, the amount of sodium bicarbonate should be the same as MS-222, as to neutralize 
the solution (Neiffer & Stamper, 2009; Priborsky & Velisek, 2018). Buffers such as sodium 
hydrogen phosphate, sodium hydroxide, imidazole, and calcium carbonate may also be 
used (Stetter, 2001; Küçük, 2010). 
MS-222 is absorbed by the gills and skin of the fish, enters the bloodstream and thenis 
distributed throughout the body (Hunn & Allen, 1974; Summerfelt & Smith 1990; Carter et 
al., 2011). Afterwards, MS-222 is rapidly metabolized in the liver by acetylation reactions, 
where primary metabolites are obtained: acetyl conjugates of ethyl m-aminobenzoate 
(nonpolar) and m-benzoic acid (polar). Its nonpolar metabolites are excreted through the 
gills, whereas polar metabolites are excreted through the kidneys according to Hunn & 
Allen, (1974) and Burka et al. (1997). 
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1.5.2 - 2-Phenoxyethanol 
The 2-phenoxyethanol (ethylene glycol monophenyl ether, C8H10O2) is an oily aromatic 
liquid, lipophilic and colourless (Coyle et al., 2004; Ross & Ross, 2008; Neiffer & Stamper, 
2009; Misawa et al., 2014). This anaesthetic is moderately soluble in water but dissolves 
better in ethanol, and remaining active in the diluted state for at least 3 days (Coyle et al., 
2004).  
According to the study of Ghanawi et al. (2013) the 2-PE is used as an anaesthetic in 
veterinary medicine and surgery as well as aquaculture. In this area, 2-phenoxyethanol is 
a popular anaesthetic because of its safety, efficacy, fast induction time, short recovery time 
(Ghanawi et al., 2013), easy preparation, low price, rapid action and also presents 
bactericidal and fungicidal properties (Priborsky & Velisek, 2018). In other studies, the 
suitability and effects of using 2-PE as an analgesic are reported Velíšek & Svobodova, 
(2004a); Mylonas et al. (2005); Weber et al. (2009); Yildiz et al. (2013), as well as its 
effectiveness in inducing both light and deep anaesthesia in aquaculture (Misawa et al., 
2014; Priborsky & Velisek, 2018). The study of Priborsky & Velisek, (2018) demonstrate the 
2-phenoxyethanol is absorbed by the gills and skin being transported by the arterial blood 
until the central nervous system, being rapidly excreted, primarily via gills, aftwerwards. As 
reported by Waterstrat, (1999) temperature is a factor that might interfer with affec the 
effects of this anaesthetic in fish. It was found that when water temperature increases, the 
efficiency of 2-phenoxyethanol also increases.  
 
1.5.3 - Clove oil 
Despite the recent interest in clove oil as a fish anaesthetic (Soto & Burhanuddin, 1995; 
King et al., 2005; Neiffer & Stamper, 2009; Javahery et al., 2012; Priborsky & Velisek, 2018), 
There are restrictions on its use in fish intended for human consumption in some countries. 
Clove oil is currently not approved by the FDA in the United States of America as a fish 
anaesthetic (Melton, 2007; Adel et al., 2016).  
The European Union has approved maximum residue limits for iso-eugenol (European 
Commission, 2011). Eugenol is the active compound of Aqui-STM (AQUI-S New Zealand, 
Lower Hutt, New Zealand), which has been approved as an anaesthetic with no withdrawal 
period in Australia, Chile, Finland, New Zealand, and the Faroe Islands, but not in the EU 
or the USA (Hoskonen & Pirhonen, 2004). Clove oil (C10H12O2) is distilled from the flowers, 
stalks, and leaves of Syzygium aromaticum (i.e. Eugenia aromaticum) or Eugenia 
caryophyllata. It is a dark brown liquid (Coyle et al., 2004; Ross & Ross, 2008; Priborsky & 
Velisek, 2018).  
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Eugenol and Iso-eugenol are active components of clove oil with a representation of 90–
95% of its weight (Priborsky & Velisek, 2018). According to Ross & Ross, (2008) the 
anaesthetic clove oil is easily dispersible in the water by vigorous shaking. But at lower  
temperatures, it can be prepared as a 10% solution in ethanol. A 10 cm3 L−1 (≈ 10 g L−1) 
stock solution is still effective after 3 months of storage at room temperature.  
In an anaesthetic immersion, the clove oil is absorbed through the gills and skin of fish 
entering the bloodstream and being distributed through the body (Hunn & Allen, 1974; 
Summerfelt & Smith 1990). Clove oil is a highly lipophilic substance. So, it adheres and 
penetrates quickly into the branchial epithelium and, once in the bloodstream, is absorbed 
into body tissues, such as adipose tissue and central nervous system (Hunn & Allen, 1974; 
Summerfelt & Smith 1990). This anaesthetic is considered as a good alternative to other 
fish anaesthetics because it is inexpensive and poses no risk to human health (Perdikaris 
et al., 2010), however, it also requires a relatively long recovery time compared to MS-222 
(Coyle et al., 2004; Neiffer & Stamper, 2009). 
This anaesthetic and the others previously mentioned are being used only in non-food fish 
and in research (Priborsky & Velisek, 2018). 
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1.6 - Characteristics of Garra rufa (Heckel, 1843) 
1.6.1 - Morphology of Garra rufa (Heckel, 1843) 
Garra rufa (Heckel, 1843) belongs to the family Cyprinidae and is one of 73 species that 
represent the genus Garra (Fig. 1, Esmaeili et al., 2009). G. rufa is a freshwater fish who 
has two pairs of barbels, a flat nose tip, a scaleless head, a developed adhesive disc, and 
has a specific crescent-shaped ventral mouth and is toothless (Jarvis, 2011; Cicek et al., 
2016). Its body form is fusiform, slightly flattened in the abdominal part. It has a visible lateral 
line system, with 31 to 38 scales, from the dorsal to the pelvic fin and the dorsal fin is anterior 
to the pelvic fin.  
The number of rays is different between fins, 12 to 14 rays the pectoral fin, 8 rays in the 
dorsal fin, 5 on the ventral fin, 7 to 8 rays in pelvic fin and 17 on the caudal fin (Jarvis, 2011). 
The body of this fish also contains medium and large size cycloid scales (Coad, 2019).  
The colour of the G. rufa´s body is variable between platinum and sliver grey, but sometimes 
a few individuals are almost black (Fig. 1). This can be explained by the fact that they can 
adapt to the brightness and the colours of their surrounding environment. Despite the 
variation of colour, their body is considered typically grey, except for their abdomen, which 
is white (Jarvis, 2011; Coad, 2019). 
 
Figure 1 - Garra rufa (Heckel, 1843). Source: Aqua Orinoco 
The total length of Garra rufa has been recorded by some researchers in different countries 
and water basins where this fish can be found as native species. In Iran, Esmaeili & 
Ebrahimi, (2006) collected and measured fish with 13 cm, as well as Yalçin-Özdilek & 
Ekmekçi, (2006) at the Asi Riser (Orontes), Turkey. 
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1.6.2 - Biogeography and ecology 
Garra rufa is geographically distributed across southern Asia, northern and central middle 
east (Jarvis, 2011; Jayasree et al., 2016; Froese, 2019). It can be found in countries like 
Israel, Jordan, Iran, Syria, Iraq and the regions around the Tigris and Euphrates River 
systems (Fig. 2) (Cicek et al., 2016).  
 
Figure 2 – Geographic distribution of the species Garra rufa (Heckel, 1843). Source: IUCN 
The doctor fish is a sub-tropical, benthopelagic and a non-migratory species,who lives in 
rivers, lakes, and small lagoons (Ruane et al., 2013). They can withstand fast waters and 
live in places with strong currents, such as rivers running from mountains. This ability is due 
to their adhesive disc, present near the mouth, which allows them to grab to a hard substrate 
(Keivany et al., 2016). 
Some studies refer that Garra rufa lives in aquatic ecosystems whose environmental 
parameters can be described as the following: temperature between 15 and 31 °C, water 
depth from 30 to 50 cm, oxygen dissolved among 6.1 and 14.8  
mg L-1, salinity ranging from 0.10-0.80, water velocity until 4.5 m s-1 and pH between 7.0 
and 9.0 (Jarvis, 2011; Cicek et al., 2016). This fish is also refered as capable of surviving in 
environments contaminated with trace metals, demonstrating to be resilient to dry periods 
and destruction of their habitat, being able to withstand more easily variations of 
temperature than oxygen (Gümgüm et al., 1994; Yazdanpanah, 2005; Jarvis, 2011; Özçelik 
& Akyol, 2011). 
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1.6.3 - Feeding habits 
Garra rufa is considered an omnivore species. Once in their natural environment, it feeds 
on macroalgae, phytoplankton, zooplankton and detritus (Teimori et al., 2011; Froese, 
2019). According to the study of Yalçin-Özdilek & Ekmekçi, (2006) gut content analysis on 
fish caught in Turkey showed the presence of bacteria and algae like Cyanobacteria, 
Chrysophyta and Chlorophyta (Navicula sp. and Gomphonema sp.), Rotifers and Protozoa.  
Garra rufa uses its adhesive disc for feeding, as the mouth pads stick to the substrate and 
the disc scratches the algae from a hard surface (Zhang, 2005; Teimori et al., 2011; Ruane 
et al., 2013). This species has as recognised predators, the European eel Anguilla anguilla 
(Linnaeus, 1758), the African catfish Clarias gariepinus (Burchell, 1822 and other cyprinids, 
like Carasobarbus canis (Valenciennes, 1842) (Jarvis, 2011; Froese, 2019). 
 
1.6.4 - Reproduction  
Garra rufa individuals are gonochoric, with no records of simultaneous or sequential 
hermaphroditism (Jarvis, 2011). Spawning occurs once a year during spring, between 
March to June in Iraq and between May to September in Iran (Ünlü, 2006; Patimar et al., 
2010; Abedi et al., 2011). Males and females of G. rufa are very similar to each other which 
makes gender separation difficult.  Nevertheless, this species has sexual dimorphism, due 
to the presence of white tubercles on the males, displayed temporarily uring the breeding 
season (Fig. 3) (Fowler & Steinitz, 1956; Jarvis, 2011). These tubercles are rounded dermal 
formations between the eyes and the nostrils (Coad, 2019). 
 
Figure 3 – Male of Garra rufa (Heckel, 1843) in the breeding season. Source: Pro Aquarium 
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Males may acquire a brighter colour during the breeding season, being slightly larger than 
females. Females may have pectoral, pelvic and anal fin bases different from males during 
the spawning period (Coad, 2019). G. rufa can be considered a broadcast spawner, as 
breeding individuals execute postures on open substrate and do not protect their eggs after 
spawning being completed (Ünlü, 2006; Jarvis, 2011). 
Sexual maturity of G. rufa varies according to different populations. In Iraq, its lifespan is 2 
or 3 years for individuals with 10 cm total length and a weight of 50 g (Al-Rudainy, 2008), 
while in Iran, G. rufa has a lifespan of 4 years, in which the older individulas reach 15 cm of 
total length and weight of 9 g (Abedi et al., 2011). 
 
1.6.5 - Ichthyotherapy 
This species is also known under the trade name doctor fish, due to the use of this fish in 
therapeutic treatments that go by the designation of Ichthyotherapy (Sayili et al., 2007; 
Jarvis, 2011; Jayasree et al., 2016). Ichthyotherapy (Fig. 4) is a treatment in which G. rufa 
uses its developed adhesive disc and mouth to remove dead skin cells from a human 
individual, around a specific part of the body in which a skin problem needs to be cured 
(Wildgoose, 2012). There are evidences that at the end of an ichthyotherapy treatment with 
G. rufa, skin becomes smooth and clean (Church, 2013). 
 
Figure 4 - Ichthyotherapy session with Garra rufa (Heckel, 1843). Author: Adriana Gaveta.  
This therapy has been used in diseases like psoriasis, eczema, acne, and other skin 
disorders (Grassberger & Hoch, 2006; Sayili et al., 2007; Church, 2013).  
Ichthyotherapy started in central Anatolia, Turkey, more specifically in the Kangal hot 
springs, which have been world-renowned since 1989 (Özçelik & Akyol, 2011; Majtán et al., 
2012; Church, 2013). Two species of fish coexist in this hot springs: the Tigris kingfish 
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Cyprinion macrostomus Heckel, 1843 and G. rufa. Both fish are members of the carp family 
Cyprinidae (Jarvis, 2011; Özçelik & Akyol, 2011; Church, 2013; Majtán et al., 2012).  
The temperature of Kangal hot springs varies between 35 °C to 37 °C (Özçelik & Akyol, 
2011; Church, 2013). Few aquatic primary producers flourish in this system at these high 
temperatures, for which a food web problem arises. C. macrostomus and G. rufa fish feed 
on phyto and zooplankton scarcing in these waters. So, they may adapt their diet and feed 
on the skin of other vertebrates that come in contact with them in the water (Özçelik & Akyol, 
2011; Church, 2013). Both fish are used to clean, soften and help treat people's skin, while  
they feed on epithelial cells. However, G. rufa is considered the principal therapeutic 
species, once it bares no teeth that could inflict harm to others subjecting themselves to 
their nibbling. Due to its recognised success in the Kangal hot springs, G. rufa has been 
propelled to be used in this type of treatments, not only in Kangal, but in spas worldwide. 
Nowadays, G. rufa is considered the key species for Ichthyotherapy (Özçelik & Akyol, 2011; 
Church, 2013).  
In spas or thermal pools, some caretakers proved small amounts of food to G. rufa, in order 
to keep them interested in nibbling and feed of epithelial cells and thus, in interacting with 
their human patients. Deprived of a normal balanced diet and, sometimes of a proper quality 
aquatic environment, these animals evidence slow growth rates, low physical and health 
conditions, that might even revert to a more aggressive and predatory behaviour (Sayili et 
al., 2007; Wildgoose, 2012). By adopting this type of procedure, animal welfare is 
undermined. Besides affecting its growth, fish can die without a proper diet (Wildgoose, 
2012). The concepts of animal welfare incorporate physical, physiological and mental states 
of each animal (Segner et al., 2019). The definition of animal welfare is based on nature, 
functions and feelings. 
According to Segner et al. (2019), the nature-based definition considers animal welfare in 
good order if the animal can engage in natural behaviour. With this concept, it will be difficult, 
if not impossible, to obtain a good welfare status for farmed fish. The function-based concept 
considers well-being satisfied if the animal is in good health and shows normal biological 
functioning and growth. Factors that affect fish welfare are water quality, high stock 
densities in tanks, handling, stress, transport and diseases (Segner et al., 2019). Water 
quality is one of the most critical factors for fish welfare and needs to be monitored more 
often. Poor water quality, or sudden changes in water parameters, can lead to acute and 
chronic health and well-being problems. The parameter values for water quality are specific 
to each species. Water quality parameters include temperature, conductivity, pH, oxygen 
concentration, nitrogenous compounds concentration assessment (ammonia, nitrite and 
nitrate) and much more (Segner et al., 2019). 
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Optimal stocking densities endorsing fish welfare depend on biological factors, such as 
species or life stage, and also on technical factors, such as water flow rates. Stocking 
density is limited by water quality and thus, has to be adjusted to maintain optimal water 
quality (Segner et al., 2019). 
Handling is necessary throughout fish production cycle. As fish are very sensitive to 
handling, this should be done as fast as possible, minimizing animal discomfort. All 
equipment used for handling must be in good hygiene and operational conditions (Segner 
et al., 2019). 
Prophylaxis of the disease is also an important aspect of fish welfare. Any introduction of 
disease agents should be avoided, as it can occur through the transfer of infected fish, the 
use of contaminated equipment or personnel. This also includes separating infected fish 
during a disease outbreak and removing any dead animals from the rearing system (Segner 
et al., 2019). But, an effective measure of disease prophylaxis is to use vaccination of fish 
against bacterial and viral diseases, in order to prevent an outbreak of disease (Segner et 
al., 2019). 
1.6.6 - Ecological Status 
Garra rufa fish are considered as a least concern species by the International Union for 
Conservation of Nature (IUCN, 2019). Nevertheless, it is referred that there is a decreasing 
population trend, mostly of mature individuals, due to many ongoing threats. Moreover, it is 
not evaluated by Convention on International Trade in Endangered Species of Wild Fauna 
and Flora (also known as the Washington convention; CITES, 2017) and Convention on the 
Conservation of Migratory Species of Wild Animals (CMS, 2015). 
In Turkey, G. rufa was listed as a vulnerable species, due to significant regional decline 
caused by overexploitation of the species for therapeutic purposes and exportation, plus 
the destruction of its natural habitats, being recently protected in legal terms (Baeck et al., 
2009; Jarvis, 2011). 
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1.7 - Objectives  
Accordingly, this study pretended to verify the viability of using the anaesthetics MS-222,  
2-phenoxyethanol and clove oil in Garra rufa fish. Moreover, it was intended to determine 
the minimum effective concentration to be used with each anaesthetic for this species, as 
well as to verify if it differed according to G. rufa’s body size. Therefore, tree size classes of 
G. rufa (small, medium and large fish) were subjected to eight different concentrations of 
MS-222 (225 to 400 mg L-1, with increments of 25 mg L-1), six concentrations of  
2-phenoxyethanol (525 to 900 mg L-1, with increments of 75 mg L-1) and four concentrations 
of clove oil (110 to 170 mg L-1, with increments of 20 mg L-1). The times for anaesthesia 
induction, monitoring and recovery phases were recorded for each fish, as well as the time 
spent in the entire procedure. During the monitoring phase, G. rufa were measured for total 
length, weighted, observed to determine the gender and verify the absence of opercular 
movements/muscle contractions. The monitoring phase was carried out for 90 seconds, to 
assess anaesthesia success for aquaculture routine procedures. The anaesthesia stages 
observed in G. rufa, according to its behaviour, were described and timed within 
anaesthesia induction and recovery phases. Statistical analyses were performed to search 
possible correlations between induction and recovery times, according to each size class, 
or even between opposite stages within each of those phases. Also, linear regressions were 
assessed to find a possible relation between the induction and recovery times towards fish 
size (total length and individual wet weight), for each anaesthetic agent. After the 
anaesthesia procedures, the fish were evaluated also in what concerns their immediate 
appetence for food and were monitored during a week for the occurrence of mortality or 
injury. 
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2. Materials and Methods  
2.1 - Acclimatisation and maintenance of Garra rufa (Heckel, 1843) 
A total of 330 G. rufa specimens from 3 size classes (small 4-5 cm, medium 6-7 cm and 
large 8-11 cm) were selected among the stock kept at the CETEMARES Bioterium 
(Polytechnic Institute of Leiria, Peniche, Portugal). Their adaptation period took place over 
2 weeks and all the individuals were kept in a freshwater recirculation system (RAS), in a 
controlled temperature room at 25 °C, where they remained until the end of the experimental 
activity. The systems consisted of three PVC shelves (EA, EB and EC), each with twelve 
aquariums distributed by three racks and one sump (Fig. 5). Each rack was illuminated by 
an 11W LED track light over four rectangular aerated aquariums of 18 L capacity. Each 
aquarium was covered with nets fixed with cloth clip springs, in order to avoid the animals 
from escaping the rearing systems. The water was directed to a 90 L sump that contained: 
aeration, a mechanical filter consisting of two glass wool sponges; a biological filter of Pure 
Water Bio-ring ceramic rings; an EHEIM reflex UV 350 ultraviolet filter of 14 W (EHEIM 
GmbH & Co KG, Stuttgart, Germany); a TMC Vecton2 400 skimmer (Tropical Marine 
Centre, London, UK) with a SICCE Syncra Silent 1.5 pump (700 - 1350 L h-1; Pozzoleone, 
Italy); an EHEIM Compact + 5000 circulation pump (2500 - 5000 L h-1; EHEIM GmbH & Co 
KG, Stuttgart, Germany) and an EHEIM JÄGGER heater of 300 W set to 28 ºC (EHEIM 
GmbH & Co KG, Stuttgart, Germany). 
The fish were randomly distributed by rearing systems, with 10 fish of the same size class 
per aquarium (Fig. 6). In fact only 240 fish were subjected to the experimental procedures. 
The remaining fish were maintained only as a precaution, to be used in the case that some 
fish could die or become injured during the experimental procedures and/or eventual 
attempts to escape from the aquaria. Each rearing system maintained also an empty 
aquarium to isolate weaken or injured fish, as to protect them from being disturbed by their 
peers. 
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Figure 5 - Garra rufa (Heckel, 1843) rearing systems. 
 
Figure 6 - Schematic distribution of Garra rufa (Heckel, 1843) fish in the rearing systems. There 
were 8 replicate aquaria for each size class and every single aquarium contained 10 fish. Plus, each 
shelf contained one empty aquarium (to isolate fish that might present small injuries) and three others 
with 10 fish each, to substitute those that could die or become ill during the procedures. 
2.2 - Water quality monitoring  
Partial water changes of the rearing systems were made once a week, at about 75 % of 
their volume. Water quality monitoring was performed three times a week. Environmental 
parameters temperature (28.90 °C), pH (8.09) and dissolved oxygen (6.94 mg L-1) were 
measured every day with a YSI Professional Plus handheld multiparameter meter (YSI 
Incorporated, Yellow Springs, United States of America).  
If the water quality parameters were outside the ranges suitable for animal welfare, a partial 
water exchange was made and environmental parameters were measured again. 
Additonally, ammonia (< 0.25 mg L-1), nitrite (< 0.25 mg L-1) and nitrate (< 5.0 mg L-1) 
18 
 
concentrations were assessed qualitatively with API - Aquarium Pharmaceuticals rapid tests 
(Mars Fishcare North America, Inc., Chalfont, Pennsylvania, United States of America).  
2.3 - Feeding 
During the acclimatisation and maintenance, G. rufa fish were fed ad libitum twice a day 
with a granulated commercial feed Dr. Bassleer Biofish Food Regular M (Aquarium Münster, 
Telgte, Germany; with 54 % crude protein, 16 % crude oils and fats, 10 % crude ash, 4 % 
crude fibre, 2 % calcium, 1.5 % phosphorus, 4,230 kcal kg-1).  
2.4 - Experimental design 
This experimental work was carried out entirely at the CETEMARES bioterium  
(Polytechnic Institute of Leiria, Peniche, Portugal), following the European legislation 
(Directive No. 2010/63 of the European Parliament, Portuguese Decree-Law No.113/2013). 
This work studied the use of three substances (MS-222, 2-phenoxyethanol and clove oil) to 
anaesthetise G. rufa from 3 different size classes at their mean rearing temperature  
(29 C). Ten fish from a random aquarium within the three rearing systems were chosen to 
induce anaesthesia, using one concentration of an anaesthetic. The three sizes classes 
were subjected to the same combination of anaesthetic × concentration in the same day. 
Previous studies showed that the concentrations 425 mg L-1 of MS-222  
(Ferreira et al., 2015a), 825 mg L-1 of 2-phenoxyethanol (Ferreira et al., 2015b) and  
130 mg L-1 clove oil (Ferreira et al., 2016), were the most suitable to anaesthetise small  
G. rufa (4-5 cm of total length). However, those studies did not use controlled temperature 
of the water, for which it dropped from 29 C (recommended temperature) to a room 
temperature of approximately 20 C, during the anaesthetic procedures. As higher 
temperatures usually potentiate the effects of anaesthetics (Prince & Powell, 2000; Walsh 
& Pease, 2002; Hoskonen & Pirhonen, 2004), a concentration immediately lower to the 
recommended ones was firstly used to anaesthetise G. rufa. Its results were evaluated, so 
as to decide which concentration should be used afterwards. The concentrations of the 
anaesthetics were increased or reduced, accordingly to the induction and recovery times 
observed, in order to comply with those recommended (3 minutes for induction and and 
less 10 minutes, respectively; Gilderhus & Marking, (1987) and Ross & Ross, (2008). In an 
effort to abide by the concept of animal welfare (Directive 2010/63/Eu, Portuguese Decree- 
Law No. 113/2013), whenever a certain anaesthetic concentration became unsuited for 
Garra rufa size class, the following increment/reduction dose was not assessed anymore 
(Table II). Accordingly, the fish were subjected to eight different concentrations of MS-222 
(225 to 400 mg L-1, with increments of 25 mg L-1), six concentrations of 2-phenoxyethanol 
(525 to 900 mg L-1, with increments of 75 mg L-1) and four concentrations of clove oil (110 
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to 170 mg L-1, with increments of 20 mg L-1). The first anaesthetic to be used was MS-222, 
then 2-phenoxyethanol and clove oil for last. The fish were left to rest for 1 month in between 
anaesthetics, in order to eliminate its residues from the organism and avoid synergistic 
effects (as the withdraw period of 21 days when using MS-222 in fish destined for human 
consumption (Hoskonen & Pirhonen, 2004; FDA, 2007; Popovic et al., 2012; Priborsky & 
Velisek, 2018). 
Table II - Concentrations of MS-222, 2-phenoxyethanol and clove oil used to anaesthetise three size 
classes of Garra rufa (Heckel, 1843). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.5 – Anaesthesia  
The fish were fasted for 24 hours prior to the anaesthetic procedures. 
Anaesthesia was carried out under controlled temperature - the same as the one in the 
rearing systems (29 C), by using water heaters and aeration within the recipients in which 
the fish were anaesthetised and recovered. 
Plastic recipients with a 5 L capacity were filled with 3 L of rearing water and placed on a 
work station (Fig. 7), by the following order: 1) one for receiving the fish from the rearing 
system and holding them until being anaesthetised (blue lid); 2) one for inducing 
 Size class 
Anaestesics Small  Medium  Large  
MS-222  
225 mg L-1 X X  
250 mg L-1 X X X 
275 mg L-1 X X X 
300 mg L-1 X X X 
325 mg L-1 X X X 
350 mg L-1 X X X 
375 mg L-1 X X X 
400 mg L-1 X X X 
2-phenoxyethanol  
525 mg L-1 X X  
600 mg L-1 X X  
675 mg L-1 X X X 
750 mg L-1 X X X 
825 mg L-1 X X X 
900 mg L-1 X X X 
clove oil  
110 mg L-1 X X X 
130 mg L-1 X X X 
150 mg L-1 X X X 
170 mg L-1 X X X 
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anaesthesia (pink lid); 3) two for recovering the animals (green lid), in order to divide a batch 
of fish and avoid the contamination of the recovering water with anaesthetic residues; and 
4) one container for holding the fish until the last one has been recovered and transfer them 
all back into their respective aquarium (blue lid). The anaesthetic solution was prepared in 
advanced and let to dissolve for 30 minutes, with strong aeration. A new solution was 
prepared for each 10 fish from a G. rufa size class. The MS-222 (Sigma-Aldrich, St. Louis, 
United States of America) was weighted in an analytical balance (AE ADAM PGL 3002, 
Milton Keynes, England, ± 0.01 g accuracy) and added to the water in the induction 
recipient, along with the same amount of sodium bicarbonate (Sigma-Aldrich, St. Louis, 
United States of America) as to buffer the solution. The clove oil (Bio clove essential oil, 
Biover Nv, Nazareth, Belgium) was firstly dissolved in ethanol at 1:10 ratio and then added 
to the water. The 2-phenoxyethanol (Sigma-Aldrich, St. Louis, United States of America) 
was added directly into the water. Before the anaesthetic procedures, the water quality in 
the recipients was assessed with a YSI Professional Plus handheld multiparameter meter, 
in order to verify if they were suitable to the fish welfare (Table III). 
Table III - Physico-chemical parameters of the water quality during the anaesthesia for the three 
anaesthetics: MS-222, 2-phenoxyethanol and clove oil. Data are expressed as mean ± SD. 
 
The anaesthetic procedures comprised three different phases: induction, monitoring and 
recovery. In each of these phases, fish behaviour was surveyed and timed according to 
several stages adapted from Coyle et al. (2004), but adjusted to the specific external signs 
exhibited by G. rufa. Ten G. rufa were taken from a random aquarium, placed in the first 
recipient and let to rest for 10 minutes.  
To induce anaesthesia by inhalation, a single G. rufa was removed with a fish net, let to drip 
the excessive water and placed in the second recipient, which had a certain amount of 
anaesthetic agent (as to obtain the desired concentration). 
The anaesthesia induction phase (I) corresponded to the time that run since immersion in 
the anaesthetic solution until cessation of the opercular movements (Summerfelt & Smith, 
1990).  
In the case of G. rufa, the following stages of anaesthesia induction were observed: 1) 
impaired motion (IM), which was the time that took for the fish to lose swimming 
coordination, after being inserted in the anaesthetic solution; 2) loss of buoyancy loss (BL) 
Anaesthetics Temperature (°C) pH Dissolved oxygen (mg L-1) 
MS-222 29.3 ± 0.41 8.40 ± 0.19 6.65 ± 0.20 
2-phenoxyethanol 29.2 ± 0.81 8.09 ± 0.05 7.04 ± 0.30 
clove oil 29.2 ± 0.67 7.95 ± 0.06 6.69 ± 0.13 
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that was the time running between the moment in which the fish lost swimming coordination 
and fell sideways on the bottom of the container; and 3) cease of opercular movements 
(COM), corresponding to the time it took for the fish to stop moving the opercula, after losing 
buoyancy. 
Afterwards, the fish were removed from the anaesthetic solution to measure their total 
length (TL) with the aid of an ichthyometer, weighted with a portable digital scale Pesola 
MS500 (± 0.1 g; PESOLA Präzisionswaagen AG, Schindellegi, Switzerland) and observed 
through the Stereo Microscope Zeiss Stemi DV4 LED (Carl Zeiss Microscopy GmbH, 
Göttingen, Germany) to determine the gender. Then, the fish were be held to detect 
muscular contractions or opercular movements until being 90 seconds out of the water. If 
the fish demonstrated any of these signs, they were immediately inserted in the recovery 
container. All these procedures were carried out during the monitoring phase (M). 
After that, the fish was placed in another recipient, containing just water from the rearing 
system, near the aeration stone. The anaesthesia recovery phase (R) was evaluated as the 
time running since the immersion of the fish in clear water until it showed voluntary and 
coordinated swimming movements. This phase comprised the following stages: 1) initiation 
of opercular movements (IOM), as the time it took for the fish to restart breathing by moving 
the opercula; 2) initiation of body movements (IBM), which corresponded to the time it took 
for the fish to present muscular contractions afterwards, in order to straighten up and swim; 
3) buoyancy control (BC) that was the time for the fish to recover its buoyancy control after 
its first attempts to swim; and 4) normal swimming (NS), as the time it took for the fish to 
swim voluntarily and co-ordinately after regaining its buoyancy control. 
For every 5 anaesthetised fish, the recovery container was changed so that there was were 
no anaesthetic residues in the water. Then, the fish was removed from the recovery 
recipient with a net, let to drip the excessive water and transferred to a last container, where 
it was left to rest. When all the 10 fish went through these steps, they were returned to their 
respective aquarium in the rearing system. 
Ten minutes later, they were given a daily dose of feed corresponding to the amount ad 
libitum (0.04 g fish-1; Catarino et al., 2019), previously weighted on an analytical balance 
Sartorius TE124S (Sartorius AG, Göettingen, Germany). Their feeding behaviour was 
observed in what concerns their appetence for food and how long it took them to ingest the 
whole daily dose of feed. The amount of food placed on the bottom of the aquarium was 
verified at each 15 minutes. If the food was not all ingested in 45 min, then it was considered 
that the fish´s appetite was impaired by the anaesthesia 
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During the following week, the fish were monitored for their survival, health state and 
behaviour. This monitoring was done by observing the fish in their respective aquariums at 
a visual level. 
 
Figure 7 - Photographs of the work station for the anaesthetic procedures in Garra rufa (Heckel, 
1843), with six recipients containing 3 L of water from G. rufa’s rearing system, a water heater set 
for 29 °C and strong aeration (a). The recipients had lids with different colour to indicate their purpose 
(b): the blue lid corresponded to recipients in the beginning and in the end of the work station, used 
to receive the fish bound to be anaesthetised and those ready to be returned to the rearing system, 
respectively (the last one was always covered with the lid to avoid G. rufa from jumping out of the 
water); the pink lid signalled the recipient with the anaesthetic solution; the green lid identified the 
containers used to recover the fish from anaesthesia,(being the first replaced by the second after 5 
fish, to avoid contamination by anaesthetic residues) 
 
 
2.6. – Data analyses 
All calculations and statistical analyses were performed with IBM SPSS™ Statistics for 
Windows, version 26 (IBM Corporation, Armonk, New York, U.S.A), with a significance level 
set as α = 0.05. The results were presented as mean ± standard error (S.E.).  
All data were tested for normality with the Kolmogorov Smirnov normality test and 
homogeneity of variances with Levene’s test. After that, two-way ANOVA (F(degrees of freedom 
between groups, degrees of freedom within groups) = value; p-value) were made, having as factors the 
anaesthetic concentration and the fish size class (independent variables). These analyses 
were applied to the induction, monitoring and recovery phases, plus the several stages 
comprised in each of them, for the three anaesthetics: MS-222, 2-phenoxyethanol and clove 
oil. In the case of statiscally significant differences, the multiple comparison post-hoc 
Bonferroni tests were performed and the respective p-values were presented. 
Linear regression analyses were performed to relate the total length (TL) and individual wet 
weight (IWW) of the fish with the induction and recovery phases, with fish from all size 
classes for each concentration of the three anaesthetics: MS-222, 2-phenoxyethanol and 
clove oil. The equation, Pearson’s correlation coefficient (r), coefficient of determination 
(R2); sample size (N) and p-value were presented. 
Pearson product-moment correlations were used to measure the strength and direction of 
association between the time it took for the fish to be anaesthetised and to recover from it, 
regardless of G. rufa’s size class and the anaesthetic concentration, or also for each fish 
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size class regardless the anaesthetic concentration. The results were expressed as 
correlation coefficient (r), sample size (N) and p-value. The strength of correlation was 
interpreted according to Evans (1996). 
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3. Results 
All Garra rufa fish were male and presented appetence for food immediately after being 
reintroduced in their rearing systems, subsequent to the anaesthetic procedures.  
In what regards the anaesthetic MS-222 (Fig. 8 a), the feeding time established for the 30 
minutes was verified for the lowest concentrations 225, and 250 and 300 mg L-1 and it 
exceeded 45 minutes for all the other concentrations. After this time, there was still food left 
in the aquariums. The medium class, fed in between 5 min to 30 min, being faster within 
the highest MS-222 concentrations. The larger fish were even faster to consume the daily 
feed dose, within 2 to 8 min. However, their feeding frenzy was faster for 300 mg L-1, 
increasing up and downwards. For the 2-PE anaesthetic (Fig. 8 b), the small class usually 
fed within 30 min, but they took 45 minutes when anaesthetised with 675 and 
750 mg L-1. In the medium size class, the feeding ranged from 9 to 30 min, decreasing 
progressively with the increasing anaesthetic doses until 825 mg L-1 . The same was verified 
for the large size class. The large fish fed faster, ranging from 4  to 8 min. 
The feeding time for the clove oil anaesthetic (Fig. 8 c) were similar to the other two 
anaesthetics for the small size class, taking at least 30 minutes to ingest the daily dose of 
feed or exceeding 45 min . 
The medium and large fish fed faster, ranging from 10 to 17 min and from 3 to 7 min, 
respectively. All size classes of fish fed faster at the intermediate clove oil concentrations 
(130 and 150 mg L-1) than in the smaller and larger anaesthetic doses. 
Regarding survival, there were no mortalities registered during the anaesthetic procedures 
and within one week time afterwards. The only exception was a single individual from the 
medium size class, 24 hours after being anaesthetised with 170 mg L-1 of clove oil. 
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Figure 8 - Absolute time that three size classes (small, medium and large) of Garra rufa (Heckel, 
1843) took to ingest the daily ad libitum dose of feed after anaesthesia with a) MS-222, b) 2-
phenoxyethanol and c) clove oil.  
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3.1 – Anaesthesia with MS – 222 
3.1.1 Total length and individual wet weight  
The fish Garra rufa measured a total length of 4.31 ± 0.42 cm within the small size class. 
For the medium size class, they measured 6.46 ± 0.85 cm and those from the large size 
class were 9.42 ± 0.70 cm (Fig. 9 a).  
There were statistically significant differences in the total length amongst all the size classes 
(Two-way ANOVA: F 2,207 =11075.458, p-value = 0.000 ˂ 0.05; Bonferroni tests with  
p-value = 0.000 < 0.05). 
There were differences between the various concentrations of MS-222, in what concerns 
the total lengths of G. rufa (Two-way ANOVA: F7,207 = 2.591; p-value = 0.014 ˂ 0.05), but 
only for concentration 225 mg L-1 of MS-222 towards all the other concentrations (Bonferroni 
tests with p-value < 0.05). 
Statistical analyses confirmed that there were no significant total length differences amongst 
the several concentrations for the medium fish (Two-way ANOVA: F7,72 = 0.898, 
p-value = 0.830 > 0.05) and large fish size classes (ANOVA: F6,63 = 0.259,  
p-value = 0.954 > 0.05). 
There was no interaction between size classes and the various MS-222 concentrations 
tested in what concerns the total length of G. rufa (Two-way ANOVA: F13,207 = 1.635;  
p-value = 0.078 ˃ 0.05). 
G. rufa presented an individual wet weight of 0.86 ± 0.70 g for the small size class, 
3.20 ± 1.62 g for the medium size class and those from the large size class weighted  
9.74 ± 1.97 g (Fig. 9 b). 
The individual wet weight of the fish from the three size classes were all significantly 
different from each other (Two-way ANOVA: F2,207 = 682.900, p-value = 0.000 ˂ 0.05; 
Bonferroni tests with p-value < 0.05).  
Contrarily to the total length, statistically significant differences in the individual wet weight 
of the fish in relation to the various concentrations of MS-222 were not obtained (Two-way 
ANOVA: F7,207 = 0.546, p-value = 0.857 > 0.05). 
Also, there was no interaction between size classes and the various concentrations of Ms-
222 tested for the individual wet weight (Two-way ANOVA: F13,207 = 3.569, p-value = 0.083 
˃ 0.05). 
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Figure 9 - Garra rufa (Heckel, 1843) a) total length and b) individual wet weight (mean ± S.E.) 
obtained in three size classes (small, medium and large fish) and eight concentrations of MS-222 
(225, 250, 275, 300, 325, 350, 375 and 400 mg L-1) assessed during the experimental trial. 
 
 
3.1.2 -Timing of the induction, monitoring and recovery phases 
3.1.2.1 Induction phase 
The induction phase (Fig. 10 a) showed statistically significant differences in length between 
all three G. rufa size classes (Two-way ANOVA: F2,207 = 43.313, p-value = 0.000 ˂ 0.05; 
Bonferroni tests with p-value < 0.05), MS-222 concentrations (Two-way ANOVA:  
F7,207 = 46.207, p-value = 0.000 ˂ 0.05), with an interaction between the 2 factors (Two-way 
ANOVA: F13,207 = 5.110, p-value = 0.000 ˂ 0.05). 
Generally, G. rufa from the largest size class presented a longer induction phase than those 
from the medium size class, regardless of MS-222 concentrations, while the smallest size 
class showed shorter induction times. The only exception was registered in the 
concentration 325 mg L-1, in which the smaller G. rufa took more time to be anaesthetised 
than the medium and even the larger fish. 
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The induction phase lasted longer in the concentrations from 225 to 300 mg L-1 of MS-222 
in relation to those from 325 to 400 mg L-1 (Bonferroni tests with p-value < 0.05). Also, the 
induction phase in this last concentration of MS-222 was significantly higher than the ones 
measured for 325 and 375 mg L-1 (Bonferroni tests with p-value < 0.05). 
In sum, the MS-222 concentrations that induced a faster anaesthesia in G. rufa were: 
375 mg L-1 for both the small (65.80 ± 11.183 s) and large (78.70 ± 21.69 s) size classes, 
plus 325 mg L-1 (64.50 ± 11, 97 s) for the medium size class. In contrast, the concentrations 
that took more time to produce an anaesthesia state were: 225 mg L-1 (118.50 ± 22.36 s) 
for the small size class, 250 mg L-1 (166.70 ± 33.50 s) for the medium size class and  
300 mg L-1 (169.90 ± 27.97) for the large size class. 
Significant linear regressions, with strong correlation and 62 to 77 % determination 
coefficients, were established between the time to induce MS-222 anaesthesia and G. rufa 
total length, plus with individual wet weight, at 275 and 300 mg L-1 (Table IV). Also, 
significant linear regressions, with moderate correlation and 18 to 42 % determination 
coefficients, were observed between the anaesthesia induction time and fish total length at 
the concentrations 225 and 350 mg L-1, plus individual wet weight at the concentrations 250 
and 350 mg L-1 (Table IV). 
 
3.1.2.2 - Monitoring phase 
The monitoring phase (Fig. 10 b) presented statistically significant differences between 
various size classes (Two-way ANOVA: F2,207 = 6.109, p-value = 0.003 ˂ 0.05), MS-222 
concentrations (Two-way ANOVA: F7,207  = 3.219, p-value = 0.003 ˂ 0.05), but with 
significant interaction between the two factors (Two-way ANOVA: F13,207 = 1.7881,  
p-value = 0.043 < 0.05). 
Bonferroni test showed that small class behaved differently from the medium and large size 
classes, enduring the full 90 s of the monitoring phase (Bonferroni tests with  
p-value = 0.008 ˂ 0.05 and p-value = 0.025 ˂ 0.05, respectively), contrarily to these last two 
groups (Bonferroni test with p-value = 1.000 > 0.05). 
The monitoring phase at MS-222 concentration 250 mg L-1 was significantly shorter than at 
325 and 350 mg L-1 (Bonferroni tests with p-value < 0.05). 
Almost all fish remained totally immobilised during the monitoring phase, during which they 
were measured, weighed and observed for gender identification. 
In the medium size class, some fish exhibited opercular movements and/or muscular 
contractions when anaesthetised with concentrations lower than 325 mg L-1 of MS-222, with 
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the shortest monitoring phase registered at 225 mg L-1 (80.90 ± 16,86 s). Within the highest 
concentrations, a single fish endured only 40 s of anaesthesia at 375 mg L-1, reducing the 
monitoring time to 85.00 ± 4.74 s. 
Likewise, fish from the large size class were maintained immobilised for 90 ± 0.00 s for 
concentrations above 325 mg L-1, with exception of two individuals at 400 mg L-1, reducing 
the monitoring time to 87.50 ± 1.99 s. The shortest monitoring phase was observed at  
250 mg L-1 (75.50 ± 17.22 s), with only 30 % of the fish enduring anaesthesia for 90 s. For 
this reason, the larger G. rufa were not submitted to the downward concentration  
225 mg L-1. 
 
3.1.2.3 - Recovery phase 
The anaesthesia recovery phase for MS-222 (Fig. 10 c) presented statistically significant 
differences amongst size classes (Two-way ANOVA: F2,207  = 21.867,  
p-value = 0.000 ˂ 0.05) and anaesthetic agent concentration (Two-way ANOVA:  
F7,207 =8.258, p-value = 0.000 ˂ 0.05), with a significant interaction between those two 
factors (Two-way ANOVA: F13,207 = 5.561, p-value = 0.000 ˂ 0.05). 
Generally, G. rufa from the small size class took longer to recover from MS-222 anaesthesia 
than those from the medium and large size classes (Bonferroni tests with  
p-value = 0.000 ˂ 0.05), with these two showing similar responses (Bonferroni test with 
p-value = 0.277 > 0.05). 
Predominantly, G. rufa took more time to recover from MS-222 anaesthesia within 
concentrations from 325 mg L-1 upwards than downwards. The recovery time measured for 
this concentration was significantly higher than that from all the other smaller anaesthetic 
doses. In the concentrations 225 and 300 mg L-1, it was also significantly lower than in all 
the other doses above 325 mg L-1 (Bonferroni tests with p-values < 0.05). 
In sum, the MS-222 concentrations in which G. rufa recovered faster from anaesthesia 
were: 225 mg L-1 for both the small (94.10 ± 37.11 s) and medium (99.40 ± 41.54 s) size 
classes, plus 300 mg L-1 (99.40 ± 41.54 s) for the large size class. In contrast, the 
concentrations that took more time to recover from an anaesthesia state were: 350 mg L-1 
(426.70 ± 203.34 s) for the small, 375 mg L-1 (225.60 ± 138.32 s) for the medium and 
325 mg L-1 (236.90 ± 153.59) for the large size classes. 
No significant linear regressions, with weak correlation and determination coefficients, were 
observed between the anaesthesia recovery time and the individual wet weight of G. rufa 
at 275 mg L-1 of MS-222 (Table IV). 
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A weak, but significant, negative correlation was found between the time it took for the fish 
to be anaesthetised and to recover from it, regardless of G. rufa’s size class and MS-222 
anaesthetic (r = -0.251, N = 230, p-value = 0.001 < 0.05). All sizes classes of G. rufa 
evidenced this trend: small (r = -0.307, N = 80, p-value = 0.006 < 0.05), medium (r = -0.229, 
N = 80, p-value = 0.0.41 < 0.05) and large fish (r = -0.259, N = 70, p-value = 0.030 < 0.05). 
  
31 
 
 Small    Medium    Large    Reference value (90s) 
 
 
In
d
u
c
ti
o
n
 p
h
a
s
e
 (
s
) 
b 
 
M
o
n
it
o
ri
n
g
 p
h
a
s
e
 (
s
) 
c 
 
R
e
c
o
v
e
ry
 p
h
a
s
e
 (
s
) 
 Concentration (mg L-1) 
Figure 10 – Timing of the a) induction , b) monitoring and c) recovery phases (mean ± S.E.) for the 
three size classes of Garra rufa (Heckel, 1843) (small, medium and large) and for the eight 
concentrations of MS-222 (225, 250, 275, 300, 325, 350, 375 and 400 mg L-1) assessed during the 
experimental trial. Note: The numbers above the columns in the monitoring phase indicate the 
number of fish that not endure 90 seconds of anaesthesia without presenting body contractions or 
opercular movements. 
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Table IV - Results of linear regression analyses performed to assess the relationship between the 
independent variables total length (TL) or individual wet weight (IWW) of Garra rufa (Heckel, 1843) 
with the dependent variables time anaesthesia induction (I) or recovery (R). Fish from all size classes 
were used in for each concentration of concentration of MS-222. Pearson’s correlation coefficient (r), 
coefficient of determination (R2), p-value, regression equation and classification of the regression 
analysis are indicated. 
Concentrations r R2 p-value Regression equation Classification 
225 mg L-1 
0.64 0.42 0.00 I = - 19.02 + 21.42 TL Significant, moderately correlated 
0.39 0.15 0.09 I = 76.92 + 8.94 IWW Non-significant, weakly correlated 
0.19 0.04 0.42 R = 26.06 + 2.84 TL Non-significant, weakly correlated 
0.00 0.00 0.99 R = - 0.008 + 41.52 IWW Non-significant, very weakly correlated 
250 mg L-1 
0.45 0.21 0.12 I = 52.33 + 7.67 TL Non-significant, moderately correlated 
0.43 0.18 0.02 I = 87.41 + 3.82 IWW Significant, moderately correlated 
0.05 0.03 0.79 R = 63.96 - 0.99 TL Non-significant, very weakly correlated 
0.05 0.03 0.78 R = 59.6 - 0.53 IWW Non significant very weakly correlated 
275 mg L-1 
0.88 0.77 0.00 I = - 6.26 + 14.3 TL Significant, strongly correlated 
0.84 0.70 0.00 I = 55.97 + 7.73 IWW Significant, strongly correlated 
0.37 0.13 0.04 R = 82.42 - 4.19 TL Significant, weakly correlated 
0.35 0.13 0.05 R = 64.37 - 2.03 IWW Non-significant, weakly correlated 
300 mg L-1 
0.84 0.71 0.00 I = - 0.84 + 14.21 TL Significant strongly correlated 
0.79 0.62 0.00 I = 64.78 + 7.31 IWW Significant strongly correlated 
0.23 0.05 0.22 R = 62.51 - 1.81 TL Non-significant weakly correlated 
0.25 0.06 0.19 R = 54.72 - 1.06 IWW Non-significant weakly correlated 
325 mg L-1 
0.04 0.00 0.84 I = 46.54 - 0.23 TL Non-significant very weakly correlated 
0.10 0.11 0.58 I = 43.56 + 0.31 IWW Non-significant very weakly correlated 
0.22 0.05 0.23 R = 67.7 + 7.06 TL Non-significant weakly correlated 
0.27 0.07 0.15 R = 92.94 + 4.28 IWW Non-significant weakly correlated 
350 mg L-1 
0.46 0.21 0.01 I = 30.61 + 3.55 TL Significant moderately correlated 
0.49 0.24 0.00 I = 43.77 + 2.15 IWW Significant moderately correlated 
0.39 0.16 0.03 R = 1.37 - 7.98 TL Significant weak correlated 
0.23 0.05 0.23 R = 97.16 - 2.6 IWW Non-significant very weakly correlated 
375 mg L-1 
0.19 0.03 0.32 I = 34.52 - 0.92 TL Non-significant very weakly correlated 
0.17 0.03 0.38 I = 38.58 + 0.46 IWW Non-significant very weakly correlated 
0.04 0.00 0.83 R = 96.85 - 0.81 TL Non-significant very weakly correlated 
0.10 0.01 0.59 R = 96.72 -1.16 IWW Non-significant very weak correlated 
400 mg L-1 
0.27 0.07 0.15 I = 49.56 + 2.88 TL Non-significant weakly correlated 
0.20 0.04 0.29 I = 64.48 + 1.09 IWW Non-significant weakly correlated 
0.05 0.00 0.78 R = 64.55 + 0.78 TL Non-significant very weakly correlated 
0.06 0.00 0.73 R= 67.7 + 0.49 IWW Non-significant very weakly correlated 
 
3.1.3 -Timing of the stages observed within the induction 
phase  
During the anaesthesia induction with MS-222, G. rufa firstly lost control of their swimming 
coordination, followed by the loss of buoyancy control, in which the fish laid sideways on 
the bottom of the container, and finally stopped breathing, which was visible by the ceasing 
of opercular movements. No exceptions were observed. Generally, the cease of opercular 
movements was the longest induction stage, followed almost equally by the other two 
stages (Fig. 11). 
3.1.3.1 Impaired motion 
G. rufa showed no statistically significant differences in the time it took them to demonstrate 
impaired motion (Fig. 11 a) when submerged in a MS-222 solution to what concerns size 
classes (Two-way ANOVA: F2,207 = 1.285, p-value = 0.279 > 0.05. Nevertheless, there were 
differences amongst the MS-222 concentrations (Two-way ANOVA: F7,207 = 10.400,  
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p-value = 0.000 ˂ 0.05) and a significant interaction between the two factors (Two-way 
ANOVA: F13,207 = 6.437, p-value = 0.000 ˂ 0.05). 
The time G. rufa took to display impaired motion was significantly higher in the smallest MS-
222 concentration (225 mg L-1) in relation to all others. The same was observed for the 
following concentration 250 mg L-1 and the highest ones that were used: 275 and  
400 mg L-1 (Bonferroni tests with p-value < 0.05).  
The time for observing G. rufa impaired motion was longer for the concentration of  
225 mg L-1 in smaller fish (19.40 ± 7.01 s), 250 mg L-1 in the medium size class 
(20.30 ± 6.53 s) and 350 mg L-1  in the larger fish (13.20 ± 3.90 s). Then again, the fastest 
impairment of swimming was observed at 400 mg L-1 both for the small and medium size 
fish (7.60 ± 2.37 s and 7.90 ± 3.04 s, respectively) and 350 mg L-1 for the large fish  
(8.60 ± 3.90 s). 
 
3.1.3.2 – Buoyancy loss 
The time spent to lose Buoyancy (Fig. 11 b) differed between G rufa size classes (Two-way 
ANOVA: F2,207 = 16.472, p-value = 0.000 < 0.05)., MS-222 concentrations (Two-way 
ANOVA: F7,207 = 6.277, p-value = 0.000 ˂ 0.05 in which there was an interaction between 
the two factors (Two-way ANOVA: F13,207 = 3.486, p-value = 0.000 ˂ 0.05). 
Fish from the large class presented statistically significant differences in comparison with 
the small and medium size ones, being less prone to lose buoyancy control (Bonferroni 
tests with p-value = 0.000 < 0.05). But, no differences were found between the other two 
size classes (Bonferroni test with p-value = 0.534 > 0.05)  
In terms of concentration, the buoyancy loss timings recorded at 250 mg L-1 were 
significantly different from those at 250 mg L-1, whilst these and those observed at  
300 mg L-1 were also significantly higher than the ones from concentrations 325 and  
350 mg L-1 (Bonferroni tests with p-value = 0.000 < 0.05).  
The loss of buoyancy took longer time at 250 mg L-1 for the small (14.80 ± 4.96 s) and large 
(20.00 ± 5.83 s) size classes, while for the medium fish it was at 300 mg L-1 with  
16.9 ± 5.30 s. In the contrary, it was faster between 325 and 375 mg L-1 for the small size 
class (6,10 ± 3.31 to 6.70 ± 3.83 s) and 325 mg L-1 for the medium (7.70 ± 4.81 s) and large 
fish (8.50 ± 2.95 s). 
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3.1.3.3 – Cease of opercular movements  
The time it took for G. rufa to cease the opercular movements (Fig. 11 c) varied significantly 
between size classes (Two-way ANOVA: F2,207 = 37.204, p-value = 0.000 ˂ 0.05), MS-222 
concentrations (Two-way ANOVA: F7,207 = 36.371, p-value = 0.000 ˂ 0.05), with interaction 
between both factors (Two-way ANOVA: F13,207 = 6.353, p-value = 0.000 ˂ 0.05). 
The period observed for the fish to cease the opercular movements was statistically shortest 
for the small size class than for the medium and large size fish (Bonferroni tests with p-
value = 0.000 ˂ 0.05), but these two were not statistically different between each other 
(Bonferroni test with p-value = 0.716 > 0.05) 
The lower MS-222 concentrations (from 225 to 300 mg L-1) presented significantly higher 
times for the cessation of opercular movements in G. rufa than those from the higher 
concentrations (from 325 to 400 mg L-1). 
For the small size class of G. rufa, the period to cease opercular movements decreased 
progressively from 250 mg L-1 (53.00 ± 18.44 s) until 375 mg L-1 (18.20 ± 8.78 s), to increase 
again at 400 mg L-1 (36.90 ± 9.76 s). The medium and large size classes followed the same 
trend, in which the opercular movements ceased briefly at 375 mg L-1 (22.90 ± 9.97 and 
16.50 ± 10.19 s, respectively), whilst the longer periods were recorded at 225 
(91.70 ± 43.91 s) and 300 mg L-1 (66.80 ± 19.81 s), respectively. 
 
3.1.4 -Timing of the stages observed within the recovery phase 
During the recovery from anaesthesia with MS-222, G. rufa generally began by initiating the 
opercular movements, followed by presenting body movements to try swimming or stand 
up straight on the bottom of the container, regaining buoyancy control. For last, the fish 
were only considered fit to be transferred to another container without supervision when 
they swam normal and voluntarily in the recovery recipient. Few exceptions were observed, 
in which G. rufa first recovered buoyancy control and then tried to swim. Generally, the 
initiation of opercular movements and the normal swimming behaviour were the longest 
recovery stages, followed by the initiation of body movements. The buoyancy control was 
the shortest one, being frequently simultaneous with the initiation of body movements 
(Fig. 11). 
3.1.4.1 Initiation of opercular movements  
G. rufa presented statistically significant difference within the times recorded for initiating 
their opercular movements (Fig. 11 c’), in what concerns size classes (Two-way ANOVA: 
F2,207 = 58.324, p-value = 0.000 < 0.05), MS-222 concentrations (Two-way ANOVA:  
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F7,207 = 9.887, p-value = 0.000 ˂ 0.05), with interaction between the two factors (Two-way 
ANOVA: F13,207 = 5.207, p-value = 0.00 ˂ 0.05). 
The initiation of opercular movements took significantly longer to occur within the small size 
than for the medium and large fish (Bonferroni tests with p-value = 0.000 ˂ 0.05), while no 
statistical differences were observed between these two last size classes (Bonferroni test 
with p-value = 1.000 > 0.05).  
Generally, the lower MS-222 concentrations (from 225 to 300 mg L-1) took significantly more 
time than the higher ones (from 325 to 400 mg L-1) to initiate the opercular movements, 
although 275 mg L-1 was only statistically different from 350 mg L-1 (Bonferroni test with 
p-value ˂ 0.05). 
The smaller G. rufa presented an increasing period to initiate their opercular movements 
after being anesthetised until the MS-222 concentration of 350 mg L-1 (81.20 ± 14.05 s), 
decreasing slightly until 400 mg L-1. The medium and large fish took more time to initiate 
opercular movements gradually until the higher concentrations that were tested  
(24.91 ± 7.39 s and 24.10 ± 10.20 s, respectively). For the smaller fish, this stage of the 
recovery phase was one of the longest ones, but for the other two size classes, it was 
comparable to the stage in which they start to move their body, being the second longest 
ones.  
Apparently, it seemed that the longer G. rufa took to cease the opercular movements during 
the anaesthesia induction, the sooner they initiated breathing during recover. However, a 
very weak negative significant correlation was found between the ceasing and the beginning 
of the opercular movements, respectively during the anaesthesia induction and recovery 
phases, in the smaller (r = -0.293, N = 80, p-value = 0.008 < 0.05 and medium fish  
(r = -0.232, N = 80, p-value = 0.038 < 0.05), ), but it was not significant for the large fish  
(r = -0.129, N = 70, p-value = 0.287 > 0.05) . 
 
3.1.4.2 Initiation of body movements  
The time taken to initiate body movements by G. rufa (Fig. 11 d), in order to swim and regain 
buoyancy, showed no statistical differences amongst size classes (Two-way ANOVA:  
F2,207 = 0.178, p-value = 0.837> 0.05), or amongst the MS-222 concentrations (Two-way 
ANOVA: F7,207 = 1.652, p-value = 0.122 > 0.05), although a significant interaction was found 
between the two factors (Two-way ANOVA: F13,207 = 2.374, p-value = 0.006 ˂ 0.05). 
This parameter presented many value fluctuations between size classes and 
concentrations, without apparent trends. It varied between 9.20 ± 2 07 s at 225 mg L-1 and 
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29.50 ± 4.76 s at 325 mg L-1 for the small fish, 9.90 ± 1.92 s at 350 mg L-1 and 32.40 ± 9.90 
s at 375 mg L-1 for the medium fish, plus 13.60 ± 1.68 s at 300 mg L-1 and 35.00 ± 11.11 s 
at 250 mg L-1 for the large fish. 
3.1.4.3 Buoyancy control  
In what concerns the buoyancy control (Fig. 11 b’), there were no statistically significant 
differences between size classes (Two-way ANOVA: F2,207 = 1.666, p-value = 0.192 > 0.05), 
or amongst MS-222 concentrations (Two-way ANOVA: (F7,207= 1.305,  
p-value = 0.249 > 0.05) neither was there an interaction between the two factors (Two-way 
ANOVA: F13,207 = 1.135, p-value = 0.331 > 0.05).  
The stage in which G. rufa gained buoyancy control was generally short. It varied from 1.70 
± 0.20 s at 300 mg L-1 and 10.40 ± 3.12 s at 350 mg L-1 of MS-222. It seemed that the 
medium and large fish from higher concentrations of MS- 222 took more time to stand up 
straight in the bottom of the recovery recipient. Some of these fish also inverted the recovery 
stages sequence (gaining buoyancy first and then starting to swim), although few situations 
were observed. 
The buoyancy loss in the anaesthesia phase was usually longer than its achievement during 
recovery. A moderate negative and significant correlation was observed between these two 
stages for small fish ( r = -0.359, N = 80, p-value = 0.001 < 0.05), but no correlation was 
observed for medium fish (r = -0.150, N = 80, p-value = 0.185 > 0.05), nor large fish  
(r = -0.095, N = 70, p-value = 0.432 > 0.05). 
 
3.1.4.4 Normal swimming 
The time taken by G. rufa to exhibit a normal and voluntary swimming behaviour (Fig. 11 
a’) presented statistically significant differences between size classes (Two-way ANOVA: 
F2,207 = 12.745, p-value = 0.000 ˂ 0.05) and MS-222 concentrations (Two-way ANOVA: 
F7,207 = 8.361, p-value = 0.000 ˂ 0.05) with interaction between the two factors (Two-way 
ANOVA: F13,207 = 3.651, p-value = 0.000 ˂ 0.05). 
The fish from the large size class took longer to achieve this stage than the small and 
medium ones (Bonferroni tests with p-value = 0.000 < 0.05), but there were no significant 
difference amongst these to last size classes (Bonferroni test with p-value = 1.000 > 0.05). 
In terms of concentrations, there were statistically significant differences regarding 
325 mg L-1 and all the other MS-222 concentrations (Bonferroni tests with p-value < 0.05), 
in which the fish have taken a longer time to achieve a normal swimming behaviour. 
Generally, this parameter took a longer time from concentration 325 mg L-1 upwards. The 
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maximum value was recorded for the large fish at 325 mg L-1 (109.50 ± 32.41 s) and the 
minimum for the small fish at 275 mg L-1 (10.40 ± 1.89 s). 
The normal swimming behaviour in the recovery phase was usually longer than motion  
impairment during the anaesthesia induction phase. A moderate negative and significant 
correlation was observed between these two stages for medium fish (r = -0.344, N = 80,  
p-value = 0.002 < 0.05), but no correlation was observed for small fish ( r = -0.144, N = 80, 
p-value = 0.203 > 0.05), nor large fish (r = -0.025, N = 70, p-value = 0.840 > 0.05). 
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ANAESTHESIA INDUCTION PHASE        
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Figure 11 – Timing of the anaesthesia stages (mean ± S.E.) identified during the induction (a 
impaired motion, b buoyancy loss and c cease of opercular movements) and recovery phases (c’ 
initiation of opercular movements, d initiation of body movements, b’ buoyancy control and a’ normal 
swimming), for three size classes of Garra rufa (Heckel, 1843) (small, medium and large) and eight 
concentrations of MS-222 (225, 250, 275, 300, 325, 350, 375 and 400 mg L-1) assessed during the 
experimental trial. 
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3.1.4.5.Total anaesthesia procedure 
The anaesthesia procedures with MS-222, which successfully immobilised the fish for 90 s 
during examination routines, varied from 273.50 ± 14.61 s for the medium fish and  
591 ± 60.31 s for the small fish, both at 350 mg L-1 (Fig. 12). 
The total time for the anaesthesia procedures presented statistically significant differences 
amongst fish size classes (Two-way ANOVA: F2,207 = 9.862, p-value = 0.000 ˂ 0.05), but 
not between MS-222 concentrations (Two-way ANOVA: F7,207 = 1.696,  
p-value = 0.112 > 0.05), with a significant interaction between factors (Two-way ANOVA: 
F13,207 = 5.699, p-value = 0.000 ˂ 0.05). 
The small and medium fish presented statistically significant differences regarding the time 
lengths for the entire procedures, varying amongst concentrations (Bonferroni test with 
p-value = 0.000 < 0.05), whilst large fish behaved in between these two, not differing from 
them (Bonferroni tests with p-value > 0.05). 
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Figure 12– Timing of the anaesthesia procedure (mean ± S.E.) for the three size classes of Garra 
rufa (Heckel, 1843) (small, medium and large) and for the eight concentrations of MS-222 (225, 250, 
275, 300, 325, 350, 375 and 400 mg L-1) assessed during the experimental trial. 
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3.2. – Anaesthesia with  2- phenoxyethanol 
3.2.1 Total length and individual wet weight  
The fish Garra rufa measured a total length of 4.53 ± 0.32 cm within the small size class, 
6.44 ± 0.90 cm within the medium size class and 9.30 ± 0.67 cm within the large size class 
(Fig. 13 a).  
G. rufa also presented an individual wet weight of 0.75 ± 0.26 g within the small size class, 
3.29 ± 1.62 g within the medium size class and 10.0 ± 2.06 g within the large size class 
(Fig. 13 b). 
Both the total length and individual wet weight were statistically different between all size 
classes (Two-way ANOVA: F2,144 = 533.756, p-value = 0.000 < 0.05 and F2,144 = 433.877,  
p-value = 0.000 < 0.05, respectively; Bonferroni tests all with p-value < 0.05). 
Likewise, there were no statistically significant differences of total length and individual wet 
weight amongst the various concentrations of 2-phenoxyethanol (Two-way ANOVA:  
F5,144 = 0.906, p-value = 0.479 > 0.05 and F5,144 = 0.061, p-value = 0.998 ˃ 0.05, 
respectively). 
Also, there were no interactions between fish size class and phenoxyethanol concentrations 
in relation to the total length and the individual wet weight of G. rufa (Two-way ANOVA: 
F8,144 = 0.358, p-value = 0.941 > 0.05 and F8,144 = 0.427, p-value = 0.903 ˃ 0.05, 
respectively). 
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Figure 13– Garra rufa (Heckel, 1843) a) total length and b) individual wet weight (mean ± S.E.) 
obtained in three size classes (small, medium and large fish) and six concentrations of 
2-phenoxyethanol (525, 600, 675, 750, 825 and 900 mg L-1). 
 
3.2.2 -Timing of the induction, monitoring and recovery phases 
3.2.2.1 Induction phase 
The induction phase (Fig. 14 a) was distinct for all size classes (Two-way ANOVA:  
F2,144 = 28.260, p-value = 0.000 ˂ 0.05, Bonferroni tests with p-value < 0.05),  
2-phenoxyethanol concentrations (Two-way ANOVA: F5,144 = 5.227, p-value = 0.000 ˂  0.05), 
with no interaction between the two factors (Two-way ANOVA: F8,144 = 1.790, 
p-value = 0.083 > 0.05). 
Generally, G. rufa from the medium size class presented a longer induction phase than 
those from the large size class, regardless of 2-phenoxyethanol concentrations, while the 
smallest size class showed shorter induction times. 
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Also, the induction phase was only significantly shorter within the fish from  
2-phenoxyethanol concentration 825 mg L-1 than in those from 525 mg L-1 (Bonferroni test 
with p-values < 0.05). 
In short, anaesthesia induction of G. rufa with 2-phenoxyethanol was faster at 825 mg L-1 
for the smaller (38.50 ± 3.13 s) and larger fish (57.90 ± 1.49 s), plus 900 mg L-1 for the 
medium ones (81.40 ± 5.46 s). On the other hand, it was longer at 525 mg L-1 within fish 
from the small (77.70 ± 5.03 s) and medium size classes (110.60 ± 9.03 s), while for the 
larger fish was at 675 mg L-1 (105.00 ± 5.01 s). 
A significant linear regression, with strong correlation and 34 % determination coefficients, 
was observed between the anaesthesia induction time and individual wet weight of G. rufa 
within 525 mg L-1 of 2-phenoxyethanol (Table V). Those with moderate correlation and 20 
to 25 % determination coefficients were obtained for the total length at 600 and 675 mg L-1, 
while for the individual wet weight was at 600 mg L-1 (Table V). 
 
3.2.2.2 Monitoring phase  
The monitoring phase (Fig. 14 b) had statistically significant differences of time between 
size classes (Two-way ANOVA: F2,144 = 4.904, p-value = 0.009 ˂ 0.05), 2-phenoxyethanol 
concentrations (Two-way ANOVA: F5,144 = 20.986, p-value = 0.000 ˂ 0.05) , plus an 
interaction between the two factors (Two-way ANOVA: F8,144 = 4.590,  
p-value = 0.000 <0.05).  
The fish from the small size class endured significantly less the monitoring period than those 
from the medium and large size classes (Bonferroni tests with p-value ˂ 0.05), with no 
statistically significant differences amongst these two last size classes (Bonferroni test with 
p-value =0.134 > 0.05).. 
Also, the monitoring phase was less endured by G. rufa subjected to the 2-phenoxyethanol 
doses lower than 675 mg L-1, in which 525 and 600 mg L-1 were statistically different 
between each other and all the other concentrations (Bonferroni tests with p-value ˂ 0.05). 
In fact, G. rufa from the small and large size classes stood anaesthetised for all 90 s from 
675 mg L-1 upwards, while those from the medium size class behaved similarly above  
750 mg L-1. As 10 % of the medium size fish recovered from anaesthesia before the end of 
the monitoring period at 675 mg L-1, it was advisable not to use lower doses of 
2-phenoxyethanol with larger fish. 
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3.2.2.3 Recovery phase 
The recovery phase (Fig. 14 c) demonstrated significantly differences within all size classes 
(Two-way ANOVA: F2,144 = 12.250, p-value = 0.000 ˂ 0.05, Bonferroni tests with  
p-value ˂ 0.05), 2-phenoxyethanol concentrations (Two-way ANOVA: F5,144 = 25.085, 
p-value = 0.000 ˂ 0.05) and an interaction between the two factors (Two-way ANOVA:  
F8,144 = 3.673, p-value = 0.001 ˂ 0.05). 
In most cases, G. rufa from the large size class presented a significantly longer recovery 
phase than those from the medium size class (except for concentration 750 mg L-1, in which 
the medium fish took more time), while those from the small size class were the fastest to 
recover (with exception of 900 mg L-1, in which the medium fish were the fastest). Also, the 
fish showed a significantly longer recovery phase in 900 mg L-1 of 2-phenoxyethanol 
regarding all the other concentrations (Bonferroni tests with p-value = 0.000 ˂ 0.05). Also, 
the recovery phase was shortest in 525 mg L-1, which was also significantly different from 
the ones recorded at 825 mg L-1. 
Summing up, G. rufa took longer to recover from 2-phenoxyethanol anaesthesia at  
900 mg L-1 for all size classes (small = 102.90 ± 7.86 s; medium = 99.90 ± 12.12 s; 
large = 114.70 ± 7.87 s). Notwithstanding, the smaller and medium fish recovered faster at 
525 mg L-1 (36.00 ± 2.17 s and 39.90 ± 39.99 s, respectively), while for the larger ones was 
at 750 mg L-1 (53.50 ± 5.35 s). 
Significant linear regressions, with strong correlation and 39 to 47 % determination 
coefficients were observed between the anaesthesia recovery time and G. rufa total length, 
plus individual wet weight, at 675 and 825 mg L-1 of 2-phenoxyethanol (Table V). 
The time it took for the fish to be anaesthetised and to recover from it, regardless of  
G. rufa’s size class and 2-phenoxyethanol anaesthetic, was not correlated 
(r = 0.129, N = 160, p-value = 0.103 > 0.05). Neither was there, when analysing the fish 
size classes separately: the small G. rufa evidenced a week positive significant correlation 
between the two phases (r = 0.262, N = 60, p-value = 0.043 < 0.05), but not the medium 
(r = 0.001, N = 60, p-value = 0.995 > 0.05), or the large size class fish (r = 0.047, N = 40, 
p-value = 0.771 > 0.05). 
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Figure 14 – Timing of the a) induction, b) monitoring and c) recovery phases (mean ± S.E.) for the 
three size classes of Garra rufa (Heckel, 1843) (small, medium and large) and for the six 
concentrations of 2-phenoxyethanol (525, 600, 675, 750, 825 and 900 mg L-1) assessed during the 
experimental trial. Note: The numbers above the columns in the monitoring phase indicate the 
number of fish that not endure 90 seconds of anaesthesia without presenting body contractions or 
opercular movements. 
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Table V - Results of linear regression analyses performed to assess the relationship between the 
independent variables total length (TL) or individual wet weight (IWW) of Garra rufa (Heckel, 1843) 
with the dependent variables of time anaesthesia induction (I) or recovery (R). Fish from all size 
classes were used in each concentration of 2-phenoxyethanol. Indication of the simple correlation 
coefficient (r), coefficient of determination (R2), p-value, regression equation and classification of the 
regression analysis. 
Concentrations r R2 p-value Regression equation Classification 
525 mg L-1 
0.67 0.46 0.00 I = - 10.76 +18.65 TL Significant, moderately correlated 
0.69 0.47 0.00 I = 68.27 + 13 IWW Significant, moderately correlated 
0.31 0.09 0.19 R = 20.74 + 3.06 TL Non-significant, weakly correlated 
0.34 0.11 0.14 R = 33.33 + 2.32 IWW Non-significant, weakly correlated 
600 mg L-1 
0.58 0.34 0.00 I = 2.05 + 14.5 TL Significant, moderately correlated 
0.50 0.25 0.02 I = 64.79 + 9.17 IWW Significant, moderately correlated 
0.22 0.05 0.34 R = 28.64 + 3.8 TL Non-significant, weakly correlated 
0.19 0.04 0.41 R = 45.05 + 2.42 IWW Non-significant ,very weakly correlated 
675 mg L-1 
0.45 0.20 0.01 I = 12.2 + 10.89 TL Significant, moderately correlated 
0.37 0.14 0.04 I = 63.8 + 4.53 IWW Significant, weakly correlated 
0.65 0.42 0.00 R = 2.89 + 8.01 TL Significant, moderately correlated 
0.63 0.40 0.00 R = 38.34 + 3.85 IWW Significant, moderately correlated 
750 mg L-1 
0.33 0.11 0.07 I = 41.03 + 4.58 TL Non-significant, weakly correlated 
0.25 0.06 0.18 I = 62.87 + 1.83 IWW Non-significant, weakly correlated 
0.19 0.03 0.33 R = 44.36 + 2.16 TL Non-significant, very weakly correlated 
0.09 0.00 0.64 R = 56.14 + 0.55 IWW Non-significant, very weakly correlated 
825 mg L-1 
0.27 0.07 0.15 I = 40.62 + 2.96 TL Non-significant, weakly correlated 
0.13 0.02 0.48 I = 92.17+ 1.80 IWW Non significant, very weakly correlated 
0.65 0.42 0.00 R = 11.85 + 8.36 TL Significant, moderately correlated 
0.62 0.39 0.00 R = 49.71 + 3.76 IWW Significant, moderately correlated 
900 mg L-1 
0.06 0.04 0.75 I = 68.46 + 0.46 TL Non-significant, very weak correlated 
0.02 0.00 0.93 I = 71.97 - 0.06 IWW Non-significant, very weakly correlated 
0.20 0.04 0.30 R = 85.54 + 2.94 TL Non- significant, weakly correlated 
0.16 0.03 0.39 R = 99.86 - 1.25 IWW Non-significant, very weakly correlated 
 
3.2.3 -Timing of the stages observed within the induction 
phase 
During the anaesthesia induction with 2-phenoxyethanol, G. rufa followed the same pattern 
observed for MS-222. The first stage observed was impaired motion (control loss of 
swimming coordination), followed by buoyancy loss (when fish laid sideways on the bottom 
of the container), and finally ceasing the opercular movements (when they stopped 
breathing). No exceptions to this sequence were observed. Also like reported for MS-222 
anaesthesia, the cease of opercular movements was the longest induction stage, followed 
almost equally by the other two stages (Fig. 15). 
3.2.3.1 Impaired motion  
G. rufa showed statistically significant differences in the time it took them to demonstrate 
impaired motion (Fig. 15 a), when submerged in a 2-phenoxyethanol solution, to what 
concerns all size classes (Two-way ANOVA: F2,144 = 21.887, p-value = 0.000 < 0.05) and 
46 
 
anaesthetic concentrations (Two-way ANOVA: F5,144 = 4.083, p-value = 0.002 > 0.05), but 
no interaction between the two factors (Two-way ANOVA: F8,144 = 1.806,  
p-value = 0.080 > 0.05). 
Generally, the smaller fish were faster to show impaired motion than the other two size 
classes, followed by the larger fish and the medium ones for last, with statistically significant 
differences amongst all them (Bonferroni tests with p-value < 0.05). 
The time G. rufa took to display impaired motion was significantly shorter in the  
2-phenoxyethanol concentration 825 mg L-1 in relation to the lowest one (525 mg L-1) 
(Bonferroni tests with p-value < 0.05).  
The time for observing G. rufa impaired motion was longer for the concentration of 
525 mg L-1 in smaller fish (15.25 ± 2.33 s), 825 mg L-1 in the medium size class  
(17.80 ± 1.32 s) and 900 mg L-1 in the larger fish (16.20 ± 1.77s). Then again, the fastest 
impairment of swimming was observed at 825 mg L-1 both for the small and large size fish 
(7.60 ± 1.06 s and 15.20 ± 1.27 s, respectively) and 900 mg L-1 for the medium fish 
(12.0 ± 1.52 s). 
 
3.2.3.2 Buoyancy loss  
The time spent to lose buoyancy (Fig. 15 b) did not differ between G. rufa size classes  
(Two-way ANOVA: F2,144 = 1.556, p-value = 0.215 > 0.05), 2-phenoxyethanol concentrations 
(Two-way ANOVA: F5,144 = 0.950, p-value = 0.451 > 0.05), not was an interaction between 
the two factors (Two-way ANOVA: F8,144 = 0.479, p-value = 0.869 > 0.05). 
The loss of buoyancy took longer time at 525 mg L-1 for the small (16.1 ± 2.25 s) and medium 
(16.2 ± 2.01 s) size classes, while for the large fish it was at 825 mg L-1 with 15.7 ± 2.13 s. 
In the contrary, it was faster between 675 mg L-1 for the small size class (10.2 ± 1.74) and 
750 mg L-1 for the medium (13.80 ± 1.60 s) and large fish (12.60 ± 2.49 s). 
 
3.2.3.3 Cease of opercular movements  
The time it took for G. rufa to cease the opercular movements (Fig. 15 c) varied significantly 
between all size classes (Two-way ANOVA: F2,144 = 21.887, p-value = 0.00 ˂ 0.05),  
2-phenoxyethanol concentrations (Two-way ANOVA: F5,144 = 4.083, p-value = 0.002 ˂  0.05), 
but there was no interaction between both factors (Two-way ANOVA: F8,144 = 1.806,  
p-value = 0.080 > 0.05). 
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The smaller fish tended to be faster to cease the opercular movements than the other two 
size classes, followed by the larger fish and the medium ones for last, with statistically 
significant differences amongst all them (Bonferroni tests with p-value < 0.05). 
The time G. rufa took to cease the opercular movements was significantly shorter in the  
2-phenoxyethanol concentration 825 mg L-1 in relation to the lowest one (525 mg L-1; 
Bonferroni test with p-value < 0.05). 
For the small and large size classes of G. rufa, the period to cease opercular movements 
decreased progressively from smallest concentrations (46.10 ± 4.79 s at 525 mg L-1 and 
77.00 ± 5.06 at 675 mg L-1) until 825 mg L-1 (18.10 ± 2.26 s and 27 ± 2.56 s), to increase 
again at 400 mg L-1 (36.90 ± 9.76 s). The medium size class showed more variance amongst 
concentrations, but also ceased the opercular movements faster and longer respectively at 
825 mg L-1 (55.20 ± 5.45 s) and 525 mg L-1 (78.40 ± 8.69 s). 
 
3.2.4 -Timing of the stages observed within the recovery phase 
G. rufa recovered from anaesthesia with 2-phenoxyethanol in the same way was for  
MS-222. It began by initiating the opercular movements, followed by presenting body 
movements, regaining buoyancy control and swimming normally for last. Also, there were 
few exceptions in which G. rufa first recovered buoyancy control and then tried to swim. 
Generally, the initiation of opercular movements and the initiation of body movements were 
the longest recovery stages, followed by the normal swimming behaviour (contrarily to what 
was observed with MS-222). The buoyancy control was the shortest one, being frequently 
simultaneous with the initiation of body movements (Fig. 15). 
 
3.2.4.1 Initiation of opercular movements  
G. rufa presented statistically significant difference within the times recorded for initiating 
their opercular movements (Fig. 15 c’), in what concerns size classes (Two-way ANOVA: 
F2,144  =3.320, p-value = 0.39 < 0.05), 2-phenoxyethanol concentrations (Two-way ANOVA: 
F5,144 = 53.299, p-value = 0.00 ˂ 0.05), with interaction between the two factors (Two-way 
ANOVA: F8,144 = 3.902, p-value = 0.00 ˂ 0.05). 
The initiation of opercular movements took significantly longer to occur within the large size 
than for the small and medium fish (Bonferroni tests with p-value = 0.000 ˂ 0.05), whilst no 
statistical differences were observed between these two last size classes (Bonferroni test 
with p-value = 0.169 > 0.05). 
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Most fish within the small and medium size classes started the opercular movements within 
the monitoring period, leading to an immediate recovery before 90s, at the lowest  
2-phenoxyethanol concentrations (525 and 600 mg L-1). From the concentration  
675 mg L-1, the time to initiate the opercular movements increased progressively. So much, 
that this parameter was significantly higher amongst all fish size classes within the 
2-phenoxyethanol 900 mg L-1 in relation to all others (small fish: 69.20 ± 3.82 s; medium 
fish: 40.10 ± 7.88 s; large fish: 50.10 ± 7.29 s; Bonferroni tests with p-values ˂ 0.05). 
No correlation was found between the ceasing of the opercular movements during the 
anaesthesia induction and the breathing initiation during recovery (r = 0.029, N = 160, 
p-value = 0. 717), or even considering the size classes individually (small: = 162, N = 60, 
p-value = 0.215 > 0.05; medium: r = 0.075, N = 60, p-value = 0.567 > 0.05 and large fish:  
r = -0.057, N = 40, p-value = 0.729 > 0.05). 
 
3.2.4.2 Initiation of body movements  
The time taken to initiate body movements by G. rufa (Fig. 15 d), in order to swim and regain 
buoyancy, showed statistical differences amongst size classes (Two-way ANOVA:  
F2,144 = 7.552, p-value = 0.001 < 0.05) and the 2-phenoxyethanol concentrations (Two-way 
ANOVA: F5,144 = 4.602, p-value = 0.001 ˂ 0.05), but no interaction was found between the 
two factors (Two-way ANOVA: F8,144 = 0.937, p-value = 0.488 > 0.05). 
The large fish took significantly more time to start moving than the small and medium fish 
(Bonferroni tests with p-values < 0.05), whilst these two groups did not differ between each 
other (Bonferroni test with p-values > 0.05). Also, G. rufa from the concentration 
750 mg L-1 showed movements significantly sooner than those from 900 mg L-1. 
This parameter presented an apparent trend to decrease until 750 mg L-1. The lower values 
for small and large size classes were observed at this concentration (9.10 ± 1.65 s and 
19.50 ± 3.57 s, respectively), whilst for the medium fish was at 675 mg L-1 (11.80 ± 3.51 s). 
Afterwards, it tended to increase again until 900 mg L-1, in which the medium and large fish 
recorded the longest times (28.80 ± 5.11 and 32.50 ± 5.24 s, respectively). On the other 
hand, the small size class recorded the longest times at 600 mg L-1 (25.10 ± 2.70 s). 
3.2.4.3 Buoyancy control 
In what concerns the buoyancy control (Fig. 15 b’), there were statistically significant 
differences between size classes (Two-way ANOVA: F2,144 = 5.849, p-value = 0.004 ˂  0.05), 
but not amongst 2-phenoxyethanol concentrations (Two-way ANOVA: F5,144 = 0.975,  
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p-value = 0.435 > 0.05) , neither was there an interaction between the two factors (Two-
way ANOVA: F8,144 = 0.735, p-value = 0.661 < 0.05). 
The stage in which G. rufa gained buoyancy control was generally short. The large fish from 
higher concentrations of 2-phenoxyethanol took significantly more time to stand up straight 
in the bottom of the recovery recipient than those from the other size classes (Bonferroni 
tests with p-values < 0.05), without significant differences amongst these two (Bonferroni 
test with p-value = 0.798 > 0.05). 
Buoyancy control was faster at 525 and 600 mg L-1, as most fish did not endure deep 
anaesthesia during the monitoring phase. In what concerns the remaining  
2-phenoxyethanol concentrations, this parameter varied from 2.40 ± 0.51 s of the small fish 
and 13.40 ± 3.09 s of the large fish, both at 675 mg L-1.  
The buoyancy loss in the anaesthesia induction phase showed similar length to its gain 
during recovery for the higher concentrations, in which the fish remained successfully 
immobilised during the monitoring phase. No correlations were found between these two 
stages for small (r = -0.112, N = 60, p-value = 0.552 > 0.05), medium (r = -0.078, N = 60, 
p-value = 0.185 > 0.05) and large fish (r = -0.012, N = 40, p-value = 0.941 > 0.05). 
 
3.2.4.4 Normal swimming  
The time taken by G. rufa to exhibit a normal and voluntary swimming behaviour (Fig. 15 
a’) presented statistically significant differences between size classes (Two-way ANOVA: 
F2,144 = 17.487, p-value = 0.000 ˂ 0.05) and 2-phenoxyethanol concentrations (Two-way 
ANOVA: Two Way ANOVA: F5,144 = 4.797, p-value = 0.000 ˂ 0.05), with interaction between 
the two factors (Two-way ANOVA: F8,144 = 6.560, p-value = 0.00 ˂ 0.05). 
In general, the fish from the small size class took a significantly longer time to achieve this 
stage than the medium and large ones (Bonferroni tests with p-value < 0.05), whilst there 
were no significant differences amongst these two last size classes (Bonferroni test with  
p-value = 0.112 > 0.05). 
In terms of concentrations, there were statistically significant differences regarding  
525 mg L-1 towards 750 and 825 mg L-1 (Bonferroni tests with p-value < 0.05). G. rufa from 
the medium size class presented longer time to achieve this stage in 750 mg L-1  
(53.50 ± 5.58 s), while the larger fish presented the same trend in 825 mg L-1  
(29.10 ± 4.78 s). The small fish took more time to achieve a normal swimming behaviour at 
600 mg L-1 (16.20 ± 1.80 s).  
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The normal swimming behaviour in the recovery phase was longer than motion impairment 
during the anaesthesia induction phase, usually in the highest 2-phenoxyethanol 
concentrations. No correlations were found between these two stages for small (r  = -0.061, 
N = 60, p-value = 0.646 > 0.05), medium (r = 0.108, N = 60, p-value = 0.413 > 0.05) and 
large fish (r = 0.001, N = 40, p-value = 0.993 > 0.05). 
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ANAESTHESIA INDUCTION PHASE        
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Figure 15 – Timing of the anaesthesia stages (mean ± S.E.) identified during the induction (a 
impaired motion, b buoyancy loss and c cease of opercular movements) and recovery phases (c’ 
initiation of opercular movements, d initiation of body movements, b’ buoyancy control and a’ normal 
swimming), for three size classes of Garra rufa (Heckel, 1843) (small, medium and large) and six 
concentrations of 2-phenoxyethanol (525, 600, 675,750, 825 and 900 mg L-1) 
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3.2.4.5 Total anaesthesia procedure  
The anaesthesia procedures with 2-phenoxyethanol, which successfully immobilised the 
fish for 90 s during examination routines, varied from 128 ± 6.44 s for the medium fish at 
350 mg L-1 and 224 ± 36.58 s for the large fish at 325 mg L-1 (Fig. 16). 
The total time for the anaesthesia procedures presented statistically significant differences 
amongst fish size classes (Two-way ANOVA: F2,144 = 35.818, p-value = 0.000 ˂ 0.05),  
2-phenoxyethanol concentrations (Two-way ANOVA: F5,144 = 5.789, p-value = 0.000 < 0.05), 
with a significant interaction between factors (Two-way ANOVA: F8,144 = 3.409, 
p-value = 0.001 ˂ 0.05). 
Predominantly, the small fish presented a significant shorter time for the entire anaesthesia 
procedures with 2-phenoxyethanol than the medium and large fish (Bonferroni tests 
with p-value = 0.000 < 0.05), but not these two last size classes amongst each other 
(Bonferroni test with p-value = 1.000 > 0.05). Also, the fish took a significant longer time to 
be handled when anaesthetised with 900 mg L-1 than with 750 and 825 mg L-1.  
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Figure 16 – Timing of the anaesthesia procedure (mean ± S.E.) for the three size classes of  
Garra rufa (Heckel, 1843) (small, medium and large) and for the six concentrations of  
2-phenoxyethanol (525, 600, 675,750, 825 and 900 mg L-1). 
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3.3. - Anaesthesia with clove oil  
3.3.1 Total length and individual wet weight  
The fish Garra rufa measured a total length of 4.41 ± 0.26 cm in the small size class, 6.48 
± 0.89 cm in the medium size class and 9.43 ± 0.54 cm in the large size classe (Fig. 17 a). 
Furthermore, G. rufa weighted 0.69 ± 0.19 g in the small size class, 3.15 ± 1.36 g in the 
medium size class and 9.86 ± 1.84 g in the large class (Fig. 17 b). 
The total length and the individual wet weight presented statistically significant differences 
between all the three size classes (Two-way ANOVA: F2,108 = 642.581,  
p-value = 0.000 ˂  0.05 and F2,108 = 528.574, p-value = 0.000 ˂  0.05, respectively; Bonferroni 
tests with p-value < 0.05). 
On the other hand, there were no statistically significant differences in the total length, nor 
in the individual wet weight of the fish, in relation to the four concentrations of clove oil (Two-
way ANOVA: F2,108 = 1.387, p-value = 0.251 ˃ 0.05 and F3,108 = 2.550,  
p-value = 0.059 ˃ 0.05, respectively). 
Moreover, there were no interactions between the three size classes and the four 
concentrations of clove oil in relation to the total length (Two-way ANOVA: F6,108 = 0.211,  
p-value = 0.973 > 0.05) and also to the individual wet weight (F 6,108 = 0.908,  
p-value = 0.492 ˃ 0.05). 
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Figure 17 – Garra rufa (Heckel, 1843) a) total length and b) individual wet weight (mean ± S.E.) 
obtained in three size classes (small, medium and large fish) and four concentrations of clove oil 
(110, 130, 150 and 170 mg L-1). 
 
3.3.2 -Timing of the stages observed within the induction 
monitoring and recovery phase 
3.3.2.1 Induction phase  
The induction phase (Fig. 18 a) was distinct for size classes (Two-way ANOVA:  
F2,108 = 5.013, p-value = 0.008 ˂ 0.05, Bonferroni tests with p-value < 0.05), clove oil 
concentrations (Two-way ANOVA: F3,108 = 2.737, p-value = 0.047 ˂  0.05), with no interaction 
between the two factors (Two-way ANOVA: F6,108 = 0.756, p-value = 0.606 > 0.05). 
Generally, G. rufa from the large size class presented a longer induction phase than those 
from the small one (Bonferroni test with p-value = 0.008 < 0.05), while the medium size 
class showed no differences regarding those two (Bonferroni tests with p-value > 0.05). 
Also, the induction phase was only significantly shorter within the fish from clove oil 
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concentration 150 mg L-1 than in those from 110 mg L-1 (Bonferroni test  
with p-values < 0.05).  
The clove oil concentrations that induced a faster anaesthesia induction in G. rufa were  
150 mg L-1, both for the small and large fish (60.90 ± 5.30 s and 101.60 ± 7.65 s, 
respectively), plus 130 mg L-1 (91.40 ± 11.90 s). On the other hand, those who took more 
time to induce anaesthesia were 110 mg L-1 for the small and large G. rufa (90.70 ± 8.80 s 
and 157.10 ± 48.24 s, respectively), plus 110 mg L-1 for the medium fish (130.10 ± 27.78 s). 
Apparently, larger G. rufa took more time to be anaesthetised than the smaller ones. 
A significant linear regression, with strong correlation and 31 % determination coefficients, 
was observed between the anaesthesia induction time and fish’s total length at 150 mg L-1 
of clove oil. Similarly, significant moderate correlations were obtained at 130 mg L-1, 
between the anaesthesia induction time and both fish’s total length and individual wet 
weight (Table VI).  
 
3.3.2.2 - Monitoring phase  
The monitoring phase (Fig. 18 b) had no statistically significant differences of time between 
size classes (Two-way ANOVA: F2,108 = 53.325, p-value = 0.535 > 0.05), clove oil 
concentrations (Two-way ANOVA: F3,108 = 1.980, p-value = 0.121 > 0.05), or an interaction 
between the two factors (Two-way ANOVA: F6,108 = 1.738, p-value = 0.119 > 0.05). 
G. rufa from all size classes endured the all 90 s of the monitoring phase without presenting 
muscular contractions and opercular movements only at 130 mg L-1 of clove oil. The 
concentration 150 mg L-1 produced similar results, except for two large fish that initiated 
breathing before that time had ended. The clove oil concentrations below and above those 
values seem to be unsuited for routine procedures regarding fish physical assessments, as 
some fish recovered from anaesthesia short after ceasing their opercular movements. 
 
3.3.2.3 - Recovery phase  
The recovery phase (Fig. 18 c) demonstrated significantly differences within G. rufa size 
classes (Two-way ANOVA: F2,108 = 4.550, p-value = 0.013 ˂ 0.05, Bonferroni tests with 
p-value ˂ 0.05), but not amongst clove oil concentrations (Two-way ANOVA: F3,108 = 1.023, 
p-value = 0.386 > 0.05), neither was there an interaction between the two factors (Two-way 
ANOVA: F6,108 = 1.231, p-value = 0.296 > 0.05). 
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Generally, G. rufa from the large size class recovered faster than those from the small one 
(Bonferroni test with p-value = 0.018 < 0.05). The medium size class showed no differences 
regarding those two (Bonferroni tests with p-value > 0.05), presenting intermediate values 
in the lowest concentrations (110 and 130 mg L-1) and longest recovery in the highest 
concentrations (150 and 170 mg L-1).  
In fact, the recovery phase lasted similar times between concentrations. Considering just 
the concentrations in which clove oil anaesthesia was effective throughout the entire 
monitoring phase, G. rufa from the medium and large size classes recovered faster at 
130 mg L-1 (106.60 ± 7.21 s and 83.50 ± 5.77 s, respectively), while those from the small 
size class were faster at 150 mg L-1 (105.10 ± 9.57 s). 
Apparently, larger G. rufa recovered faster from anaesthesia than smaller ones. 
Significant linear regressions, with moderate correlation and 26 % determination 
coefficients, were observed between the anaesthesia recovery time and G. rufa´s total 
length, as well as individual wet weight, at 130 mg L-1 of clove oil (Table VI). 
The time it took for the fish to be anaesthetised and to recover from it, regardless of  
G. rufa’s size class and clove oil anaesthetic, were very weakly and positively correlated 
(r = 0.295, N = 120, p-value = 0.001 < 0.05). However, when analysing the fish size classes 
separately: the small G. rufa evidenced a strong positive significant correlation between the 
two phases (r = 0.737, N = 40, p-value = 0.000 < 0.05), while it was moderate for the medium 
fish (r = 0.413, N = 40, p-value = 0.008 < 0.05) and weak for the large fish  
(r = 0.346, N = 40, p-value = 0.029 < 0.05).   
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Figure 18 – Timing of the a) induction, b) monitoring and c) recovery phases (mean ± S.E.) obtained 
in three size classes of Garra rufa (Heckel, 1843) (small, medium and large fish) and four 
concentrations of clove oil (110, 130, 150 and 170 mg L-1).  
Note : The numbers above the columns in the monitoring phase indicate the number of fish that not 
endure 90 seconds of anaesthesia without presenting body contractions or opercular movements. 
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Table VI - Results of linear regression analyses performed to assess the relationship between the 
independent variables total length (TL) or individual wet weight (IWW) of Garra rufa (Heckel, 1843) 
with the dependent variables time anaesthesia induction (I) or recovery (R). Fish from all size classes 
were used in each concentration of clove oil. Pearson’s correlation coefficient (r), coefficient of 
determination (R2), p-value, regression equation and classification of the regression analysis are 
indicated. 
Concentrations r R2 p-value Regression equation Classification 
110 mg L-1 
0.33  0.11 0.00 I = 35.49 + 9.45 TL Significant, weakly correlated 
0.29  0.09 0.00 I = 79.12 + 4.46 IWW Significant, weakly correlated 
0.22  0.05 0.02 R = 138.77 - 3.97 TL Significant, weakly correlated 
0.25  0.06 0.06 R = 123 - 2.38 IWW Significant, weakly correlated 
130mg L-1 
0.51  0.26 0.00 I = 48.93 + 5.64 TL Significant, moderately correlated 
0.51  0.31 0.00 I = 71.59 + 3.46 IWW Significant, moderately correlated 
0.51  0.26 0.00 R = 154.45 - 7.47 TL Significant, moderately correlated 
0.51  0.26 0.00 R = 122.47 - 4.14 IWW Significant, moderately correlated 
150 mg L-1 
0.60  0.31 0.00 I = 24.72 + 8.87 TL Significant, moderately correlated 
0.49  0.24 0.00 I = 65.57 + 4.35 IWW Significant, moderately correlated 
0.05  0.00 0.98 R = 111.11 + 0.09 TL Significant, very weakly correlated 
0.07 0.00 0.69 R = 115 - 0.74 IWW Non-significant, very weakly correlated 
170 mg L-1 
0.33  0.11 0.08 I = 42.16 + 8.85 TL Non-significant, weakly correlated 
0.24  0.06 0.20 I = 87.47 + 3.19 IWW Non-significant, weakly correlated 
0.15  0.02 0.42 R = 3.57 - 6.18 TL Non-significant, very weakly correlated 
0.05  0.02 0.80 R = 123 - 0.31 IWW Non-significant, very weakly correlated 
 
3.3.3 -Timing of the stages observed within the induction 
phase  
During the anaesthesia induction with clove oil, G. rufa followed the same pattern observed 
for the other two anaesthetics (MS-222 and 2-phenoxyethanol). The stages of induction 
observed were impaired motion (control loss of swimming coordination), followed by 
buoyancy loss (when fish laid sideways on the bottom of the container) and cease of the 
opercular movements (stop breathing). No exceptions to this sequence were observed. The 
buoyancy loss was the shortest stage to attain, followed by motion impairment and cease 
of opercular movements was by far the longest one (Fig. 19). 
 
3.3.3.1 Impaired motion 
G. rufa showed statistically significant differences in the time it took them to demonstrate 
impaired motion (Fig. 19 a), when submerged in a clove oil solution amongst size classes 
(Two-way ANOVA: F2,108 = 18.485, p-value = 0.000 < 0.05), but not in what concerns 
anaesthetic concentrations (Two-way ANOVA: F3,108 = 1.649, p-value = 0.182 > 0.05). 
Although a significant interaction was found between the two factors (Two-way ANOVA: 
F6,108 = 2.496, p-value = 0.027 < 0.05). 
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Generally, the large fish were slower to show impaired motion than those from the other two 
size classes (Bonferroni tests with p-value =0.000 < 0.05), with no statistically significant 
differences amongst small and medium fish (Bonferroni test with p-value = 1.000 > 0.05). 
The fastest times for observing G. rufa impaired motion were: 12.10 ± 1.05 s for the small 
fish at 150 mg L-1, 12.20 ± 0.77 s for the medium fish at 130 mg L-1 and 14.80 ± 1.72 s for 
the large fish at 170 mg L-1. 
 
3.3.3.2 – Loss of buoyancy 
The time spent to lose buoyancy (Fig. 19 b) did present statistically significant differences 
between G. rufa size classes (Two-way ANOVA: F2,108 = 3.737, p-value = 0.027 < 0.05), but 
not for clove oil concentrations (Two-way ANOVA: F3,108 = 1.495, p-value = 0.220 > 0.05), 
nor was an interaction between the two factors (Two-way ANOVA:  
F6,108 = 0.786, p-value = 0.583 > 0.05). 
Generally, the smaller fish were faster to lose control of their buoyancy ability than those 
from the medium size classe (Bonferroni test with p-value =0.047 < 0.05), but they did not 
differ statistically from the large fish, neither did these last ones from the medium fish 
(Bonferroni tests with p-value > 0.05). Times varied from 7.00 ± 1.10 s for the small fish at 
170 mg L-1 and the 18.20 ± 3.17 s for the large fish at 110 mg L-1 of clove oil. 
 
3.3.3.3 – Cessation of opercular movements  
The time it took for G. rufa to cease the opercular movements (Fig. 19 c) varied significantly 
between G. rufa size classes (Two-way ANOVA: F2,108 = 3.245, p-value = 0.043 < 0.05), but 
not for clove oil concentrations (Two-way ANOVA: F3,108 = 2.480, p-value = 0.065 > 0.05), 
nor was an interaction between the two factors (Two-way ANOVA: F6,108 = 0.312, 
p-value = 0.720 > 0.05). 
The smaller fish tended to cease the opercular movements faster than those from the large 
size class (Bonferroni test with p-value = 0.047 < 0.05), but not from the medium ones, 
neither did these two last group of fish differed one from the other (Bonferroni tests 
with p-value < 0.05). 
The time G. rufa took to cease the opercular movements was apparently shorter in the 
lowest and highest clove oil concentrations (110 and 170 mg L-1) than in the intermediate 
ones (130 and 150 mg L-1). The times varied from 36.50 ± 5.75 s from the small fish  
at 130 mg L-1 and 118.60 ± 48.48 s from the small fish at 110 mg L-1. 
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3.3.4 -Timing of the stages observed within the recovery phase 
G. rufa recovered from clove oil anaesthesia in the same way as for the other two 
anaesthetics (MS-222 and 2-phenoxyethanol). The first recovery sign was seeing opercular 
movements. These occurred shortly after the insertion of the fish in clean water. It was 
followed by muscular contractions, in order to resume swimming, which was often a long 
stage to attain. Then, the fish were able to control their buoyancy ability, almost always 
immediately to the initiation of body movements. Finally, G. rufa ended up swimming normal 
and voluntarily, largely the longest stage to accomplish (Fig. 19). Rare exceptions were 
observed, in which G. rufa first recovered buoyancy control and then tried to swim. 
3.3.4.1 Initiation of opercular movements  
G. rufa presented statistically significant difference within the times recorded for initiating 
their opercular movements (Fig. 19 c’) between G. rufa size classes (Two-way ANOVA: 
F2,108 = 9.080, p-value = 0.000 < 0.05), but not for clove oil concentrations (Two-way 
ANOVA: F3,108 = 0.950, p-value = 0.419 > 0.05), or was an interaction between the two 
factors (Two-way ANOVA: F6,108 = 0.743, p-value = 0.118 > 0.05). 
Generally, the initiation of opercular movements took significantly longer to occur within the 
small size class than for the medium and large fish (Bonferroni tests with p-value = ˂ 0.05), 
whilst no statistical differences were observed between these two last size classes 
(Bonferroni test with p-value = 1.000 > 0.05). 
Apparently, G. rufa regained opercular movements sooner within the lowest and highest 
clove oil concentrations (110 and 170 mg L-1) than in the intermediate ones (130 and  
150 mg L-1). Considering just the concentrations in which clove oil anaesthesia was effective 
throughout the entire monitoring phase, G. rufa from the medium and large size classes 
recovered the opercular movements faster at 150 mg L-1 (16.00 ± 3.33 s and 10.80 ± 1.79 
s, respectively), while those from the large size class were faster at 130 mg L-1 (6.90 ± 1.09 
s). 
No correlation was found between the ceasing of the opercular movements during the 
anaesthesia induction and the breathing initiation during recovery (r = 0.006, N = 120,  
p-value = 0. 945), nor even considering the size classes individually for medium (r = -0.188, 
N = 40, p-value = 0.244 > 0.05) and large fish (r = 0.006, N = 40, p-value = 0.970 > 0.05). 
Notwithstanding, the small fish presented a strong positive correlation, in which those fish 
that took longer to stop breathing also took longer to restart the opercular movements  
(r = 0.626, N = 40, p-value = 0.000 < 0.05). 
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3.3.4.2 Initiation of body movements 
The time taken to initiate body movements by G. rufa (Fig. 19 d) showed statistical 
differences amongst size classes (Two-way ANOVA: F2,108 = 3.270, p-value = 0.042 < 0.05) 
and clove oil concentrations (Two-way ANOVA: F3,108 = 4.083, p-value = 0.009 < 0.05), with 
an interaction between the two factors (Two-way ANOVA: F6,108 = 0.786,  
p-value = 0.583 < 0.05). 
The small fish took significantly less time to start moving than the large fish (Bonferroni test 
with p-values = 0.41 < 0.05), whilst the medium fish did not differ from those two fish size 
classes (Bonferroni tests with p-values > 0.05).  
Apparently, G. rufa from the lowest clove oil concentrations moved sooner than those from 
the highest ones, but there were statistically significant differences only between the 
130 mg L-1 and 170 mg L-1 (Bonferroni test with p-values < 0.05). 
Within the clove oil concentrations that produced an effective anaesthesia during the 
monitoring phase, the fastest times to produce body movements were recorded for small 
fish at 150 mg L-1 (54.60 ± 7.50 s), while for the medium and large fish was at 130 mg L-1 
(42.70 ± 4.49 s and 29.70 ± 5.30 s, respectively). 
 
3.3.4.3 Buoyancy control  
In what concerns the buoyancy control (Fig. 19 b’), there were no statistically significant 
differences between size classes (Two-way ANOVA: F2,108 = 0.959, p-value = 0.387 > 0.05), 
or amongst clove oil concentrations (Two-way ANOVA: F3,108 = 0.656,  
p-value = 0.581 > 0.05), but there was an interaction between the two factors (Two-way 
ANOVA: F6,108 = 2.520, p-value = 0.025 < 0.05).  
The stage in which G. rufa gained buoyancy control was generally short. It varied from 2.70 
± 0.53 s of the medium fish at 170 mg L-1 and 17.60 ± 4.32 s of the large fish, both  
at 130 mg L-1. 
The buoyancy loss in the anaesthesia induction phase showed similar length to its gain 
during recovery for the higher concentrations, in which the fish remained successfully 
immobilised during the monitoring phase. No correlations were found between these two 
stages, regarding the fish from all size classes (r = -0.152, N = 120, p-value = 0.098 > 0.05), 
or for just small (r = -0.215, N = 40, p-value = 0.182 > 0.05), medium (r = 0.008, N = 40, 
p-value = 0.961 > 0.05) and large fish (r = -0.250, N = 40, p-value = 0.120 > 0.05). 
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3.3.4.4 - Normal swimming  
The time taken by G. rufa to exhibit a normal and voluntary swimming behaviour (Fig. 19 
a’) presented statistically significant differences between size classes (Two-way ANOVA: 
F2,108 = 5.869, p-value = 0.004 < 0.05), but not amongst clove oil concentrations (Two-way 
ANOVA: F3,108 = 1.702, p-value = 0.171 > 0.05), neither an interaction between the two 
factors (Two-way ANOVA: F6,108 = 1.965, p-value = 0.077 < 0.05).  
In general, the fish from the medium size class took a significantly longer time to achieve 
this stage than the small and large ones (Bonferroni tests with p-value < 0.05), whilst there 
were no significant differences amongst these two last size classes (Bonferroni test with  
p-value = 1.000 > 0.05). This stage lasted from 18.10 ± 2.81 s to of 47.20 ± 9.06 s, by small 
fish at 170 mg L-1 and 110 mg L-1, respectively. 
The normal swimming behaviour in the clove oil recovery phase took longer to achieve than 
the motion impairment during the anaesthesia induction phase. No correlations were found 
between these two stages for all fish (r = -0.133, N = 120, p-value = 0.149 > 0.05), neither 
for just small (r = -0.004, N = 40, p-value = 0.982 > 0.05), medium  
(r = -0.025, N = 40, p-value = 0.877 > 0.05), or large fish  
(r = -0.153, N = 40, p-value = 0.345 > 0.05). 
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ANAESTHESIA INDUCTION PHASE        
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Figure 19 – Timing of the anaesthesia stages (mean ± S.E.) identified during the induction (a 
impaired motion, b buoyancy loss and c cease of opercular movements) and recovery phases (c’ 
initiation of opercular movements, d initiation of body movements, b’ buoyancy control and a’ normal 
swimming), for three size classes of Garra rufa (Heckel, 1843) (small, medium and large) and four 
concentrations of Clove oil (110, 130, 150 and 170 mg L-1). 
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3.3.4.5 - Total anaesthesia procedure  
In the end, the total time for the anaesthesia procedures presented no statistically significant 
differences amongst fish size classes (Two-way ANOVA: F2,108 = 0.944,  
p-value = 0.392 > 0.05), or among clove oil concentrations (Two-way ANOVA: F3,108 = 1.899, 
p-value = 0.134 > 0.05), without a significant interaction between factors (Two-way ANOVA: 
F6,108 = 0.613, p-value = 0.719 > 0.05). 
The anaesthesia procedures with clove oil, which successfully immobilised the fish for 90 s 
during examination routines, varied from 166.00 ± 14.21 s for the small fish and  
218.10 ± 23.74 s for the medium fish, both at 150 mg L-1 (Fig. 20). 
 
 
 
 
 
 
 
 
 
Figure 20 – Timing of the anaesthesia procedure (mean ± S.E.) for the three size classes of  
Garra rufa (Heckel, 1843) (small, medium and large) and for the four concentrations of Clove oil (110, 
130, 150 and 170 mg L-1). 
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4. Discussion 
Garra rufa food intake after anaesthesia at 20 °C was previously described by Ferreira et 
al. (2015a, 2015b, 2016). The fish usually showed immediate appetence for food, after 
being subjected to all the three anaesthetics: MS-222, 2-phenoxyethanol and clove oil. Plus, 
they ingested their daily dose of food within a monitoring time of 30 min. In this study, G. 
rufa presented a similar behaviour, although the small fish took longer to ingest the same 
amount of feed. The dose administered was based on the work of Catarino et al. (2019), 
who determined that G. rufa with a total length of 4.80 ± 0.025 cm were satisfied every day 
with 0.04 g of feed per fish (0.17 kcal day−1 fish−1; 3.2% of the body weight), correspondent 
to an ad libitum situation. Therefore, the present results sugest that the effects of the 
anaesthetics at 29 °C may bide for some time within the metabolism of this species, 
impairing its appetite, as the small fish had similar size and conditions to those studied by 
Ferreira et al. (2015a, 2015b, 2016) and Catarino et al. (2019). On the other hand, the 
medium and large G. rufa were very fast to ingest the food given to them. Afterwards, they 
still manifested some frenzy on the sight of their caretakers, for which they were given more 
food that was immediately consumed. Thus, it may be necessary to study in the future the 
dose of food required by larger G. rufa fish to be satiated, in order to satisfy their nutrional 
requirements and abide with animal welfare ethics. 
The influence of anaesthesia has been approached in other studies, with different fish 
species. Anaesthesia with 80 mg L-1 of MS-222 and 40 mg L-1 of clove oil caused a reduction 
of feed consumption in juveniles of rainbow trout Oncorhynchus mykiss at a temperature of 
12.6 °C (Pirhonen & Schreck, 2003). The fish were able to recover, presenting increased 
food intake 4 hours later. 
Nevertheless, Pirhonen & Schreck, (2003) verified that the non-anaesthetised fish (control 
group) still ingested 15 to 20 % more food than the ones subjected to the anaesthetics within 
a period of 24 to 48 hours afterwards . 
Also, Soto & Burhanuddin, (1995) observed that most rabbit fish Siganus lineatus 
(Valenciennes, 1835) had eaten the food given to them, within a few hours after being 
anesthetized with clove oil. Moreover, the siberian sturgeon Acipenser baerii (Brandt, 1869) 
was anaesthetised with 350 mg L-1 of clove oil by Akbulut et al. (2012). These authors found 
that the effects of this anaesthetic on feed consumption continued 4 hours after anaesthesia 
was performed, in which anaesthetised fish took longer to ingest the feed than non-
anesthetized ones (control group). The longest feeding time was recorded in the 10 min 
after anaesthesia, being 4 minutes for anaesthetised fish and 2 minutes for control fish 
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(Akbulut et al., 2012). Because of the probability of interfering with the digestive system, 
Fish are fasted for 12 to 24 hours prior to anaesthesia in order to reduce the risk of 
regurgitation of food that may lodge in the gills or foul the water (Ross & Ross, 1999). 
Fasting also decreases fecal contamination of water used for anaesthesia and recovery.  
The exact mechanism by which MS-222, 2-phenoxyethanol and clove oil act to supress the 
nervous system in fish and reduce sensory perception are still cryptic (Popovic et al., 2012; 
Zahl et al., 2012). All of them are mostly absorbed by the gills and also through the skin, 
acting systemically to reach the body tissues (Carter et al., 2011). According to Burka et al. 
(1997), Matthews & Varga, (2012), plus Balko et al, (2018), MS-222 operates at the level of 
the peripheral and central nervous system, decreasing neuronal activity. It acts on the 
sodium channels of neurons, blocking them. MS-222 inhibits the sodium entrance into the 
nerve cell and thus, limiting the depolarization of the plasma membrane, plus the 
consequent electric nerve impulse (Carter et al., 2011) and/or muscle contraction (Priborsky 
& Velisek, 2018). This anaesthetic also acts, but to a lesser extent, on the potassium 
pathways of nerve membranes, being a muscle relaxant (Matthews & Varga, 2012). 
The exact mechanism of 2-phenoxyethanol anaesthetic effect in fish has not been fully 
described (Priborsky & Velisek, 2018). For the anaesthetic 2-phenoxyethanol, it has been 
suggested by Burka et al. (1997) that the anaesthesia mechanism involves an expansion 
of neuronal cell membranes. The study of Zahl et al. (2012) demonstrated that 2-
phenoxyethanol exerted some inhibitory activity on N-methyl-d-aspartate (NMDA) receptor, 
which is a glutamate receptor and ion channel protein found in nerve cells. Its activation 
results in the opening of an ion channel that is nonselective to cations, causing the 
depolarisation of the plasma membrane and originates the electric nerve impulse.  
The anaesthetic clove oil is a highly lipophilic substance, which is rapidly distributed by the 
circulatory system and incorporated in the body tissues, especially the fat and nervous 
tissues (Priborsky & Velisek, 2018). It decreases neurosensory functions by affecting the 
nervous system, especially the cerebral cortex (Fernandes et al., 2017). In addition to 
NMDA inhibition (Zahl et al., 2012), clove oil potentiates gamma-amino butyric acid type A 
(GABAa) receptor (Zahl et al., 2012). In vertebrates, GABA is the chief inhibitory 
neurotransmitter in the central nervous system. It binds to specific transmembrane 
receptors in both pre- and postsynaptic plasma membranes, at inhibitory synapses in the 
brain. GABA induces the opening of ion channels, allowing the flow of either negatively 
charged chloride ions into the cell or positively charged potassium ions out of the cell, 
causing a negative change in the transmembrane potential (usually resulting in 
hyperpolarization). 
68 
 
In what concerns the anaesthesia recovery, MS-222 is rapidly metabolised by acetylation 
reactions and, together with its non-polar metabolites, is mainly excreted through the gills 
(Wayson et al., 1976 in Carter et al., 2011). Unmetabolised MS-222 and its polar 
metabolites are mostly excreted by the kidneys (Burka et al., 1997; Wayson et al., 1976 in 
Carter et al., 2011). MS-222 half-time was estimated at 1.5 to 4 hours (Hunn & Allen, 1974 
in Carter et al., 2011), being undetected in body fluids passed 8 to 24 hours after exposure 
(Burka et al., 1997; Wayson et al., 1976 in Carter et al., 2011). This anaesthetic is generally 
accepted as a good agent for anaesthesia, euthanasia and sedation, reccomended for 
several procedures and routine operations (Popovic et al., 2012). MS-222 is one of the few 
approved to be used in fish destined to human consumption, both by the United States of 
America (FDA, 2007) and European Union, as long as a withdrawal period of 21 days is 
applied. After all, MS-222 is regarded as a potential carcinogenic (Pirhonen & Schreck, 
2003). Morover, it represents several disadvantages: 1) may have selective toxicity for 
poikilotherms due to their low metabolic rate of the liver (Wayson et al., 1976); 2) its addition 
to the water causes pH changes, harmful for aquatic animals (Priborsky & Velisek, 2018); 
3) it is quite expensive to acquire and 4) abides safety protocols for its use (Popovic et al., 
2012) . Therefore, the research for other alternative anaesthetics continues. 
On the other hand, 2-phenoxyethanol is rapidly excreted, mainly by the gills, and its half-life 
was estimated in 30 min (Imamura-Kojima et al.,1987). But it is known to fail in supressing 
involuntary muscle reflexes. Thus, it may not be an effective anaesthetic and it is not 
recommended for surgical procedures. Also, fish subjected to this substance are known to 
recover often in an abrupt manner (Priborsky & Velisek, 2018). Moreover, 2-phenoxyethanol 
is an irritant substance, for which it should be handled with care. 
Eugenol is the main component of the clove oil (83 – 95 %). It is rapidly and almost 
completely excreted through the kidneys within 24 hours (Fischer et al., 1990 in Javahery 
et al., 2012), having a 12.4 hours half-life in rainbow trout tissues (Guénette et al., 2007). 
But the gills are also appointed as an excretion pathway for this anaesthetic in fish. Under 
repeated administration, eugenol may accumulate in the fish’s tissues and become 
potentially toxic (Guénette et al., 2007; Priborsky & Velisek, 2018). In high doses, eugenol 
may be a cytotoxic, namely for liver and kidney cells (Javahery et al., 2012). Eugenol is 
known for its antioxidant, anti-inflammatory, antimicrobial, antitumor, antimutagenic, and 
antigenotoxic activities; however, it may present some toxicity depending on the type of 
histological structure exposed to this compound and the concentration used (Jaganathan & 
Supriyanto, 2012; Barboza et al., 2018). Clove oil is considered generally regarded as safe 
(GRAS; FDA, 2007) and has different applications, such as food additive, flavouring and 
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fragance agent, or even as a an attractant pheromone for insects (Moustafa et al., 2012). 
Due to its market accessibility, price and rapid effects, it is a promising anaesthethic to be 
used for husbandry and transport of fish. Nonetheless, one other component of the clove 
oil is meythyleugenol, present in trace amounts, known to be carcinogenic (WHO, 2013). 
For this reason, the anaesthetic active compounds in clove oil have been selected to 
produce AQUI-S (AQUI-S New Zealand, Lower Hutt, New Zealand), an aquatic anaesthetic 
that has been approved in New Zealand, Australia, Chile, and Vietnam for animal 
husbandry, transportation and harvesting operations with a zero withholding period, plus 
Norway, Iceland and the Faroe Islands (but without clearance for harvesting) (AQUI-S, 
2020). 
For the above reasons, clove oil and 2-phenoxyethanol are not approved for use on fish 
intended for human consumption (Priborsky & Velisek, 2018). Almost all (if not all) 
anaesthetics have problematic issues associated, whose negative impacts can be reduced 
if optimal concentrations and operation conditions are employed to minimize and reduce 
stress in fish (Summerfelt & Smith, 1990; Priborsky & Velisek, 2018). 
Studies on anaesthetics and concentrations to be used on Garra rufa are scarce (Ferreira 
et al., 2015a, 2015b, 2016; Aydin et al., 2019). 
In this study, the fish Garra rufa were subjected to the influence of three anaesthetics: MS-
222, 2-phenoxyethanol and clove oil: Induction and recovery times recorded were within the 
time limit recommended by Gilderhus & Marking, (1987) and Ross & Ross, (2008). 
According to these authors, fish should be anaesthetised within 3 minutes, in order to not 
compromise animal welfare. Also, a successful recovery should occur in less than 10 
minutes and all anaesthetised fish must survive. 
The three anaesthetics used in this experimental trial induced a deep anaesthesia in G. rufa 
for routine processes, but not all concentrations were effective. For the medium and large 
G. rufa size classes, MS-222 concentrations from 225 to 375 mg L-1 were ineffective, since 
the fish did not last the 90 s of the monitoring phase without opercular movements and/or 
body contractions. Concerning the 2-phenoxyethanol anaesthetic, the concentrations 525 
and 600 mg L-1 shown to be ineffective for the small size class, while for the medium size 
class it were those bellow 675 mg L-1 and all the large fish endured anaesthetised the entire 
monitoring phase from this concentration upwards. 
In what concerns clove oil, fish from the small and medium size classes did not hold 90 s of 
monitoring at 110 and 170 mg L-1 and for the large class the concentration 150 mg L-1 was 
also ineffective. 
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Balancing the faster induction and recovery phases, plus holding the full monitoring period 
anaesthetised, which resulted in a shorter total anaesthesia procedure, the recommended 
dose of MS-222 for G. rufa at 29 °C is 300 mg L-1 for the small G. rufa size class, whilst for 
the medium and large size fish should be 350 mg L-1. The most effective doses to 
anaesthetise G. rufa at 29 °C resulted from a compromise between faster induction and 
recovery phases, which resulted in a shorter total anaesthesia procedure, plus holding the 
full monitoring period deeply anaesthetised. This balance for anaesthesia with MS-222 
differed between size classes, with lower doses being effective for smaller fish and higher 
doses were required for larger size classes. A concentration of 300 mg L-1 worked better for 
these animals, being induced, monitored and recovered in 146 ± 6.44 s. For the medium 
fish it was 350 mg L-1, being prossessed within 128 ± 6.88 s. And for last, the large fish  
were better anaesthetised using 375 mg L-1 being prossessed in 167 ± 21.13 s. It was not 
possible to establish a relationship between the induction and recovery times for MS-222. 
On the other hand, the 2-phenoxyethanol concentration that worked better for G. rufa did 
not differ much between size classes. But the dose 750 mg L-1 produced better results for 
the large fish (total procedures in 168 ± 8.46 s) which was lower than the 825 mg L-1 
endorsed for the small and medium fish (total procedures in 116 ± 7.80 s and 197 ± 12.27 
s, respectively). Like MS-222, it was not possible to establish a relationship between 
induction and recovery times for 2-phenoxyethanol. 
In contrast with the two other anaesthetics, the recommended dose of clove oil for G. rufa 
at 29 °C was 130 mg L-1 for all size classes (total procedures in 202 ± 17 s for the small 
size, 182 ± 9.39 s for the medium and 189 ± 11.43 s for the large size). Even though  
150 mg L-1 worked good as well (except for one large fish that did not endure 90 s of 
monitoring without presenting opercular or body movements). There was no correlation 
between the induction and recovery times and it was not possible to establish a relationship 
between them from this anaesthetic as well. The anaesthesia procedures were all carried 
in average under 5 min per fish, regardless of the anaesthetic and concentrations that were 
used. Nevertheless, for the effective concentrations of clove oil and 2-phenoxyethanol 
lasted less than 3 min 50 s, while for MS-222 was slightly faster (less than 3 min). 
The G. rufa fish were anaesthetised in warm water at 29 °C and the concentrations used 
were also high. This situation can be explained by the fact that this cyprinid fish is found in 
natural habitats with temperature ranging between 15 and 31 °C (Jarvis, 2011). However, 
the optimal rearing temperatures are between 28 and 30 °C (Catarino, 2015; Gomes, 2016). 
Bellow 24 ° C, G. rufa behave letargic, ignore food and are propense to diseases, namely 
skin and organ lesions caused by Aeromonas sp. (Ferreira SMF, personal observation). 
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Whereas in other studies using also warm water, higher temperatures seem to increase the 
effect of an anaesthetic by increasing the recovery time of anaesthetized fish (Weyl, et al., 
1996; Stehly & Gingerich, 1999; Prince & Powell, 2000; Walsh & Pease, 2002; Hoskonen 
& Pirhonen, 2004). 
According to Coyle et al. (2004), cold water species respond to lower concentrations of 
anaesthetics than warm water species, as higher temperatures increase the diffusion rate 
of the anaesthetics dissolved in the water into the fish’s gills. Moreover, when fish are 
exposed to higher ambient temperatures, their basal metabolism is (or becomes) more 
elevated and hence, they present a higher oxygen rate. With the increase in oxygen rate, 
breathing accelerates, as well as blood flow. Considering that the gills are the main pathway 
to absorb the anaesthetics, as well as to excrete it, the increasing ventilation and cardiac 
rates lead to the absorption of larger quantities of anaesthetics (Zahl et al., 2011; Javahery 
et al., 2012), thus reducing the induction time. Likewise, the excretion of the anaesthetic will 
be faster, resulting in faster recovey times (Javahery et al., 2012). Notwithstanding, it is 
imperative to provide strong aeration, both in the anaesthetic solution and also in the 
recovery system, as the concentration of dissolved oxygen in the water decreases with 
temperature (Ross & Ross, 2008; Neiffer & Stamper, 2009). 
In the study of Aydin et al. (2019), Garra rufa were exposed to two different temperatures 
(15 and 25 °C) and concentrations from 110.2 to 551.0 mg L-1 of 2-phenoxyethanol, plus 
26.5 to 106.0 mg L-1 of clove oil. These authors observed that with the increasing 
concentration for both anaesthethics, at both temperatures, the induction time decrease, 
while the recovery time increased. A similar trend was observed for Senegalese sole Solea 
senegalensis Kaup 1858 (Weber et al., 2009), kelp grouper Epinephelus bruneus Bloch, 
1793 (Park et al., 2008), rainbow trout O. mykiss (Yildiz et al., 2013) and goldfish C. auratus 
(Küçük & Çoban, 2016). However Perdikaris et al. (2010) found that the induction time of 
goldfish C. auratus size class 20 to 25 cm at 18 °C increased with concentration, as well as 
the rainbow trout O. mykiss in all sizes class at 12 °C. The recovery time increased in both. 
Aydin et al. (2019) recommended the minimum effective concentration of 330.6 mg L-1 of 2 
phenoxyethanol for both temperatures (15 °C and 25 °C). For clove oil, these authors 
recommended the minimum of 79.5 mg L-1 at 15 °C and 53.0 mg L-1 at 25 °C. All these 
concentrations are bellow the ones endorsed in the present study, in spite of the similar size 
of the fish (G. rufa weighted 1.29 ± 0.24 g, which was in between the actual small and 
medium classes) and the extra higher 4 °C. Nevertheless, Aydin et al. (2019) did not refer 
any monitoring period between induction and recovery, that might be effective for routines 
procedures to evaluate the fish’s behaviour, physical, physiological and health conditions. 
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In other studies using Garra rufa fish, Ferreira et al. (2015 a,b, 2016) used an ambient 
temperature of 20 °C to determine the most effective MS-222, phenoxyethanol and clove 
oil concentrations in fish measuring from 4 to 6 cm total length and approximately an 
individual wet weight of 0.86 to 1.28 g (correspondent to the small size class in the present 
work). These authors reached the conclusion that 425 mg L-1 of MS-222, 825 mg L-1 of 2-
phenoxyethanol and 130 mg L-1 of clove oil were the advisable concentrations. In relation 
to the present work, those results were slightly superior, substantiating the trend theory that 
higher temperatures within the species tolerance amplitude do turn anaesthesia more 
effective. So, with higher temperatures, the same concentration of anaesthetic will, in 
theory, reduce the induction and recovery times, thus shortening the entire process. If these 
phases are already fast, then lower concentrations may be employed, as the results in this 
work may confirm towards the results of Ferreira et al. (2015a,b), but not those of 2-
phenoxyethanol of Aydin et al., (2019). Clove oil results were more ambiguous. Besides the 
fact that the most effective concentration of this anaesthetic was the same despite G. rufa 
size class, it was also the same regarless the water temperature (20 or 29 °C), when 
compared to the results of Ferreira et al. (2016). Still, the concentration 130 mg L -1 was 
twice as higher than those recommended by Aydin et al. (2019), even though these authors 
did recommend a lower concentration for a higher temperature. 
The reduction of the anaesthetic effective doses with higher temperatures might be 
beneficial or useful, as to minimise toxicity, tissue accumulation or residual metabolites in 
the fish. Thus, it will help assuring safer procedures both for animals and their caretakers. 
The anaesthesia procedures should be planned and carried out in manner to avoid or 
reduce stress, as stressed animals exhibit abnormal reactions to anaesthesia and may 
require higher doses for induction, manisfest undesirable behaviour during the monitoring 
phase and demand longer recovery periods (Zahl et al., 2012). 
During this experimental assay, no mortality was observed within 24 hours after the 
anaesthesia procedures, regardless of the anaesthetic that was used. 
A single exception was observed, one fish belonging to the medium size class 
anaesthetised at a concentration of 170 mg L-1 of clove oil. One possible explanation for 
this mortality could have been its long-time exposure to the anaesthetic. This fish presented 
the longest induction time recorded during the assay - 412 seconds (6.87 min) and the 
longest recovery time of 660 seconds (11 min). Weak and sick animals are prone to make 
a difficulty recover from anaesthesia (Coyle et al., 2004), which could have also been the 
case for that specific individual, although, no external signs of disease were observed. 
Clove oil is reported to induce faster efficient anaesthesia than other anaesthetics (Sladky 
et al., 2001; Bressler & Ron 2004, Detar & Mattingly 2004 all in Neiffer & Stamper, 2009), 
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but longer recoveries. According to Mylonas et al. (2005) and Misawa et al. (2014), clove 
oil was the anaesthetic agent with the longest recovery time, whilstand MS 222 had the 
shortest one, with 2-phenoxyethanol in between. Keene et al. (1998) explained that the 
shorter recovery times for MS-222 were based on different effects on the cardio-respiratory 
system of the fish, resulting in increased respiratory and heart rates, which in turn removed 
excess anaesthetic.  
In this case, G rufa recovered faster with 2-phenoxyethanol (in average < 100 s) than MS-
222 and clove oil (both in average < 125 s) for the most effective concentrations. Clove oil 
prolonged recovery times have been reported for several teleostei fish, such as: coral reef 
ambon damsel Pomacentrus amboinensis Bleeker, 1868 (Munday & Wilson 1997); in 
rainbow trout O. mykiss (Keene et al., 1998), non-salmonids like lake sturgeon Acipenser 
fulvescens (Rafinesque, 1817), smallmouth bass Micropterus dolomieu Lacépède, 1802, 
walleye Sander vitreus (Mitchill, 1818) and northern pike Esox lucius Linnaeus, 1758 
(Peake, 1998). Other authors have also mentioned a narrow safety margin, as for the red 
pacu Piaractus brachypomus (G. Cuvier, 1818) in comparison with MS-222 (Sladky et al., 
2001), and increased sensitivity to eugenol and AQUI-S in preliminary studies with southern 
stingrays Dasyatis americana Hildebrand & Schroeder, 1928 (DLN author in Neiffer & 
Stamper, 2009). Clove oil has also been reported to cause mortality in sockeye salmon 
Oncorhynchus nerka (Walbaum, 1792) (Woody et al., 2002) and red pacu P. brachypomus 
(Sladky et al., 2001).  
Sladky et al. (2001) suggested that mortality could be due to clove oil toxicity, whose effects 
induced ventilatory failure and medullar collapse. Misawa et al., (2014) demonstrated also 
serious effect on the goldfish C. auratus respiratory center in the medulla than that of 2-
phenoxyethanol and MS-222. Moreover, clove oil is as a lipidic substance that might adhere 
to gills epithelial cells, forming an outer layer that will prevent gas exchanges (Sladky et al., 
2001). It might even cause mild gill necrosis, as observed for asian sea bass Lates calcarifer 
(Bloch, 1790) subjected to repeated exposure of low eugenol doses (Afifi et al., 2001). 
Although, Misawa et al. (2014) have considered 2-phenoxyethanol to be safer than clove 
oil, Weyl et al. (1996) stated that the repeated use of 2-phenoxyethanol increases fish 
tolerance to this anaesthetic. 
Also, clove oil might no be indicated for invasive or other deleterious procedures, once that 
it is a complex of several substances. Fish may produce physiological reactions when in 
contact with the anaesthetics. Sladky et al. (2001) also reported that red pacus P. 
brachypomus reacted more to a hypodermic needle puncture when using clove oil than MS-
222. Additionally, clove oil is known to induce and increase of epidermal mucous, namely 
in rainbow trout O. mykiss (Velíšek et al., 2005a), common carp Cyprinus carpio Linnaeus, 
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1758 (Velíšek et al., 2005b) and sheatfish Silurus glanis Linnaeus, 1758 (Velíšek et al., 
2006). Fish produce this mucous to protect their skin against abrasion, which is also a 
barrier to pathogenic elements, besides turning them more slippery and difficult for 
predators to grab them. In this case, it seems that the epidermal globlet cells are stimulated 
to produce more mucous in response to the astringent action of the anaesthetic.  
Furthermore, this reaction has also been reported for 2-phenoxyethanol for the same 
species rainbow trout O. mykiss (Velíšek & Svobodová, 2004a), common carp C. carpio 
(Velíšek & Svobodová, 2004b) and sheatfish S. glanis (Velíšek et al., 2007b). Although it 
was not an intended aim, it was possible to notice that G. rufa subjected to clove oil 
produced more mucous during the monitoring phase, while it was being handled for 
biometrics and verification of their physical status. 
Park et al. (2008) generalised that the higher the concentration of anaesthetic used, the 
shorter was the induction time and conversely, the longer was the recovery time. This trend 
was observed in the use of 2-phenoxyethanol and clove oil in G. rufa, by Aydin et al. (2019). 
However, taking into account other studies, other fish species revealed that anaesthesia 
with higher concentrations may have benefits, since it may result in both shorter induction 
and recovery times, namely the European sea bass Dicentrarchus labrax (Linnaeus, 1758) 
and the gilthead sea bream Sparus aurata Linnaeus, 1758 (Mylonas et al., 2005, Table VII). 
Therefore, higher concentrations of anaesthetic may be necessary for certain fish to be 
deeply anaesthetised, as is the case of G. rufa. The concentrations used in this study were 
higher compared to other species (Table VII). 
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Table VII - Comparison of results obtained for anaesthesia of several fish species with MS - 222, 2-phenoxyethanol (2-PE) and clove oil. Indication of 
anaesthetic, its effective concentrations, fish size (length and/or weight, when relevant), environmental conditions (salt, brackish and freshwater and 
respective temperatures) by different authors (Note : M - male; F – female; S - small and L – large). 
 
 
Species 
 
Anaesthetic 
 
Concentrations 
 
Type of 
Water 
 
Temperatur
e of 
Water 
 
Induction 
Time 
 
Recovery 
Time 
 
Reference 
Channel catfish 
 
Ictalurus punctatus 
(Rafinesque, 1818) 
 
Ictaluridae 
Clove oil 75 and 100 mg L-1 Freshwater 
Warm 
23 °C 
75 – 5.50 min 
100 – 5.17 min 
75 – 6.53 min 
100 – 3.77 min 
Waterstrat, 
1999 
Nile tilapia 
 
Oreochromis niloticus 
(Linnaeus, 1758) 
 
Cichlidae 
2-PE 600, 750 and 900 mg L-1 Freshwater 
Warm 
28 °C 
600 – 3.17 min 
750 – 2.92 min 
900 – 1.67 min 
600 – 4.5 min 
750 – 2.83 min 
900 – 2.5 min 
Mello et al., 
2012 
Discus 
 
Symphysodon discus 
(Heckel, 1840) 
 
Cichlidae 
MS-222 75 and 100 mg L−1 (3.6 g) Freshwater 
Warm 
27 °C 
75 – 1.10 min 
100 – 1 min 
75 – 1.20 min 
100 – 2 min 
Chambel et 
al., 2013  
Angelfish 
 
Pterophyllum scalare 
(Lichtenstein, 1823) 
 
Cichlidae 
MS-222 
160 mg L-1 
(4.45 cm, 2.5 g) 
Freshwater 
Warm 
24 - 25 °C 
160 – 3.31 min 160 – 5.19 min 
Mitjana et 
al., 2014 
2-PE 
800 mg L−1 
(4.45 cm, 2.5 g) 
800 – 2.36 min 800 – 4.67 min 
Clove oil 
100 mg L−1 
(4.45 cm, 2.5 g) 
100 – 2.31 min 100 – 3.31 min 
Southern platyfish 
 
Xiphophorus maculatus 
(Günther, 1866) 
 
Poeciliidae 
Clove oil 
100 and 200 mg L−1  
(0.2 – 0.5 g) 
Freshwater 
Warm 
27 °C 
100 – 1.07 min 
200 – 0.47 min 
100 – 3.40 min 
200 – 4.10 min 
Hoshiba et 
al., 2015 
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Green swordtail 
 
Xiphophorus helleri 
Heckel, 1848 
 
Poeciliidae 
MS-222 125 and 150 mg L−1 (1.3 g) Freshwater 
Warm 
27 °C 
125 – 2.33 min 
150 – 1.3min 
125 – 2.07 min 
150 – 2 min 
Chambel et 
al., 2013 
Guppy 
 
Poecilia reticulata 
Peters, 1859 
 
Poeciliidae 
 
MS-222 
125, 150 and 200 mg L−1  
(3.6 g) 
Freshwater 
Warm 
27 °C 
125 – 3.31 min 
150 – 1.83 min 
200 – 1.42 min 
125 – 1 min 
150 – 1.20 min 
200 – 130 min 
Chambel et 
al., 2013 
Clove oil 
125 and 150 mg L−1  
(1.5 - 3.5 cm) 
(0.04 – 0.5 g) 
Freshwater 
Warm 
30 °C 
125 – 1.72/2.08 min (F/M) 
150 – 1.32 min (F) 
125 – 3.60/4.65 min (F/M) 
150 – 3.62 min (F) 
Cunha et al., 
2015 
MS-222 180 mg L−1 
Freshwater 
Warm 
25 °C 
180 – 2.12 /2.02 min (M/F) 180 – 4.17 / 3.34 min (M/F) 
Mitjana et 
al., 2018 
2-PE 
1000 and  
1200 mg L−1 
1000 – 4.49 /4.14min (M/F) 
1200 – 3.11 /3.87 min (M/F) 
1000 – 3.93 /2.31min (M/F) 
1200 – 3.88 /4.27min (M/F) 
Clove oil 50 and 75 mg L 
50 – 2.28 /4.41 min (M/F) 
75 – 2.19 /2.40 min (M/F) 
50 – 3.79 /3.32 min (M/F) 
75 – 4.95 /3.96 min (M/F) 
Zebra fish 
 
Danio rerio 
(Hamilton, 1822) 
 
Cyprinidae 
MS-222 
75, 100 and 125 mg L−1 
(0.5 g) 
Freshwater 
Warm 
27 °C 
75 – 1.66 min  
100 – 1.33 min 
125 – 1.20 min 
75 – 0.68 min 
100 – 0.75 min 
125 – 0.80 min 
Chambel et 
al., 2013 
Doctor fish 
 
Garra rufa 
(Heckel, 1843 
 
Cyprinidae 
MS-222 
425 mg L-1 – small fish (4 
cm) 
Freshwater 
Cold 
20 °C 
425 – 0.77 min 425 – 1.04 min 
Ferreira et 
al., 2015a 
2-PE 
825 mg L-1– small fish (4 
cm) 
825 – 0.94 min 825 – 1.12 min 
Ferreira et 
al., 2015b 
Clove oil 
130 mg L-1– small fish (4 - 
6 cm) 
130 – 1.5min  130 – 4 min 
Ferreira et 
al., 2016 
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2-PE 
330.6 mg L-1 – 15 & 25 °C 
(1.3 g) 
Freshwater 
Cold 
15 °C 
& 
Warm 
25 °C 
330.6 mg L-1 – 1.57 min 15 °C 
330.6 mg L-1 – 1.33 min 25 °C 
330.6 mg L-1 – 2.91 min 15 °C 
330.6 mg L-1 –1.98 min 25 °C 
Aydin et al., 
2019 
Clove oil 
79.5 mg L-1 – 15 °C 
53.0 mg L-1 – 25 °C 
(1.3 g) 
79.5 mg L-1 – 2.71 min 15 °C 
53.0 mg L-1 – 2.79 min 25 °C 
79.5 mg L-1 – 5.37 min 15 °C 
53.0 mg L-1 – 5.29 min 25 °C 
MS-222 
300 mg L-1 – small fish (4 
cm) 
350 mg L-1 – medium fish 
(6.5 cm) 
375 mg L-1 – large fish (9 
cm) 
Freshwater 
Warm 
29 °C 
300 mg L-1 – 1 min  
350 mg L-1 – 0.80 min  
375 mg L-1 – 0.72 min  
300 mg L-1 – 0.87 min  
350 mg L-1 – 0.77 min 
375 mg L-1 – 1.36 min 
Present 
work, 2020 
2-PE 
825 mg L-1 – small fish (4 
cm) 
825 mg L-1 – medium fish 
(6.5 cm) 
750 mg L-1 – large fish (9 
cm) 
825 mg L-1 – 0.82 min) 
825 mg L-1 – 1.09 min 
750 mg L-1 – 0.89 min 
825 mg L-1 – 0.64 min 
825 mg L-1 – 1.4 min 
750 mg L-1 – 1.18 min  
Clove oil 
130 mg L-1 – small fish (4 
cm) 
130 mg L-1 – medium fish 
(6.5 cm) 
130 mg L-1 – large fish (9 
cm) 
130 mg L-1 – 1.29 min 
130 mg L-1 – 1.26 min 
130 mg L-1 – 1.76 min  
130 mg L-1 – 2.07 min 
130 mg L-1 – 1.77 min 
130 mg L-1 – 1.4min 
Bighead carp 
 
Hypophthalmichthys nobilis 
(Richardson, 1845) 
 
Cyprinidae 
2-PE 771 mg L-1 Freshwater 
Warm 
26 °C 
771 – 1.83 min 771 – 1.84 min 
Akbary et 
al., 2016 
Koi carp  
Cyprinus carpio) 
Linnaeus, 1758 
 
Cyprinidae 
MS-222 125 and 200 mg L-1 Freshwater 
Warm 
24 – 25 °C 
Not analysed Not analysed 
Bailey et al., 
2013 
Common carp  
(Cyprinus carpio) 
Linnaeus, 1758 
 
Cyprinidae 
Clove Oil 30, 40 and 50 mg L -1 Freshwater 
Temperate 
20 °C 
30 – 3.77 min 
40 – 2.33 min 
50 – 1.23 min 
30 – 4.43 min 
40 – 3.77 min 
50 – 3.98 min 
Hajek et al., 
2006 
Goldfish 
 
Carassius auratus 
MS-222 200 mg L-1 Freshwater 
Warm 
25.6 °C 
200 – 3.86 min 200 – 5.13 min 
Küçük & 
Çoban, 2016 
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(Linnaeus, 1758) 
 
Cyprinidae 
2-PE 551 mg L-1 Freshwater 
Temperate 
20 °C 
 
Hot 
25 
and 
30 °C 
551 – 1-1.9 min 
 
551 – 1-1.5 min 
 
551 – 1.9-2.8 min 
551 – 4.8-5.6 min 
 
551 – 3.7-5.5min 
 
551 – 3.6-4.7 min 
Weyl et al., 
1996 
Clove oil 150 mg L-1 Freshwater 
Temperate 
18 °C 
150 – 1.54 min 150 – 4.19 min 
Perdikaris et 
al., 2010 
Silver carp  
 
Hypophthalmichthys molitrix 
(Valenciennes, 1844) 
 
Cyprinidae 
2-PE 
551, 771 and 
992 mg L-1 
Fresh 
Water 
Temperate 
20.5 °C 
551 – 4.67 min 
771 – 2.67 min 
992 – 2 min 
551 – 1.33 min 
771 – 2.5 min 
992 – 5.5 min 
Hedayati, 
2018 
Far eastern catfish 
 
Silurus asotus 
Linnaeus, 1758 
 
Siluriformes 
MS-222 300 and 400 mg L-1 
Freshwater 
Temperate 
26-27 °C 
300 – 1.28 /2.83 min (S/L) 
400 – 0.93 /1.67 min (S/L) 
300 – 1.8 /4.75 min (S/L) 
400 – 1.9 /4.57 min (S/L) 
Park, 2019 
Clove oil 300 and 400 mg L-1 
300 – 0.95 /1.72 min (S/L) 
400 – 0.7 /1.10 min (S/L) 
300 – 2.18 /3.05 min (S/L) 
400 – 2.15 /2.98 min (S/L) 
Yellow perch 
 
Perca flavescens 
(Mitchill, 1814) 
 
Perciformes 
MS-222 250 and 300 mg L-1 Freshwater 
Temperate 
22 °C 
250 – 1.58 min 
300 – 1.41 min 
250 –  1.51 min 
300 –1.56 min 
Zhai et al., 
2018 
Hickory shad  
 
Alosa mediocris 
(Mitchill, 1814) 
 
Clupeidae 
MS-222 75 and 100 mg L-1 
Freshwater 
Cold 
11.1 – 13 °C 
75 – 1.5 min 
100 – 1min 
75 – 4 min 
100 – 2.5 min 
Matsche, 
2017 
2-PE 100 and 400 mg L-1 
100 – 2.5 min 
400 – 1.3 min 
100 – 4.7 min 
400 – 4.3 min 
Eugenol 50 and 100 mg L-1 
50 – 1.8 min 
100 – 1 min 
50 – 4.5 min 
100 – 3.3 min 
Rainbow trout 
 
MS-222 60 mg L-1 at 150 mg L-1 Freshwater 
Cold 
12 °C 
1.7 – 3.3 min 5.2 – 6.2 min 
Ross & 
Ross, 2008 
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Oncorhynchus mykiss 
(Walbaum, 1792) 
 
Salmonidae 
2-PE 200 and 300 mg L-1 Not analysed Not analysed 
Velíšek & 
Svobodová, 
2004a) 
Clove Oil 50 mg L-1 50 – 2.02 min 50 – 2.72 min 
Perdikaris et 
al., 2010 
Persian sturgeon 
 
Acipenser persicus 
Borodin, 1897 
 
Acipenseridae 
2-PE 330m g L-1 
Brackish 
water 
Temperate 
21.5 °C 
330 – 5.5 min 330 – 4.75 min 
Adel et al., 
2016 
Clove oil 25 and 50 mg L-1 
25 – 7.04 min 
50 – 2.11 min 
25 – 5.73 min 
50 – 10.76 min 
Senegalese sole 
 
Solea senegalensis 
Kaup, 1858 
 
Soleidae 
MS-222 100 mg L-1 
Saltwater 
Warm 
14 °C 
100 – 2.25 min 100 – 2.99 min 
Weber et al., 
2009 
2-PE 500 and 600 mg L-1 
500 – 4.37 min 
600 – 1.50 min 
500 – 5.47 min 
600 – 1.94 min 
Clove oil 30 and 40 mg L-1 
30 – 3.16 min 
40 – 1.66 min 
30 – 3.76 min 
40 – 3.59 min 
Marbled spinefoot 
 
Siganus rivulatus 
Forsskål & Niebuhr, 1775 
 
Siganidae 
MS – 222 100 and 125 mg L-1 
Saltwater 
Warm 
25.6 °C 
100 – 3.07 min 
125 – 2.14 min 
100 – 1.71 min 
125  –1.73 min 
Ghanawi et 
al., 2013 
2-PE 500 and 600 mg L-1 
500 – 1.53 min 
600 – 1.12 min 
500 – 2.18 min 
600 – 2.10 min 
Clove oil 70 and 100 mg L-1 
70 – 0.98 min 
100 – 0.77 min 
70 – 4.53 min 
100 – 4.19 min 
Meagre 
 
Argyrosomus regius 
2-PE 400 and 550 mg L-1 Saltwater 
Temperate 
18 °C 
400 – 4.76 min 
550 – 4.03 min 
400 – 4.31 min 
550 – 4.69 min 
Barata et al., 
2016 
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(Asso, 1801) 
 
Sciaenidae 
Clove oil 70 and 85 mg L-1 
70 – 3.06 min 
85 – 2.47 min 
70 – 6. 72 min 
85 – 6.53 min 
Atlantic halibut 
 
Hippoglossus hippoglossus 
(Linnaeus, 1758) 
 
Pleuronectidae  
MS – 222 80 mg L-1 
Saltwater 
Cold 
8 °C 
80 – 1.9 min  
80 – 3.22 min 
80 – 9.78 min 
80 – 12.43 min 
Zahl et al., 
2011 
2-PE 600 mg L-1 
600 – 2.52 min 
600 – 2.72 min 
600 – 15.42 min 
600 – 18.5 min 
European sea bass 
 
Dicentrarchus labrax 
(Linnaeus, 1758) 
 
Moronidae 
2-PE 300 and 350 mg L-1 
Saltwater 
Cold 
15 °C 
 
& 
 
Warm 
25 °C 
At 15 °C 
300 – 3 min 
At 25 °C 
350 – 1 min 
At 15 °C 
300 – 5 min 
At 25 °C 
350 – 3 min 
Mylonas et 
al., 2005 
Clove oil 30 mg L-1 and 40 mg L-1 
At 15 °C 
30 – 2.5 min 
At 25 °C 
40 – 1 min 
At 15 °C 
30 – 7 min 
At 25 °C 
40 – 2.5 min 
Gilthead sea bream 
 
Sparus aurata 
Linnaeus, 1758 
 
Sparidae 
2-PE 300 mg L-1 and 450 mg L-1 
 
At 15 °C 
300 – 7 min 
 
At 25 °C 
450 – 1.5 
min 
 
At 15 °C 
300 – 8 min 
 
At 25 °C 
450 – 4 min 
Clove oil 40 mg L-1 and 55 mg L-1 
At 15 °C 
55 – 3 min 
At 5 °C 
40 – 2 min 
At 15 °C 
55 – 6.5 min 
At 25 °C 
40 – 4.5 min 
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The effective dose of MS-222 to achieve deep anaesthesia varies between 20 and  
480 mg L-1 (Popovic et al., 2012). This range of effective concentrations is large because it 
includes freshwater and saltwater species, as well as, different sizes of fish. For freshwater 
species such as grass carp Ctenopharyngodon idella (Valenciennes, 1844) this range is 
among 20 to 75 mg L-1; in common carp C. carpio is from 25 to  
100 mg L-1 and in  tench Tinca tinca (Linnaeus, 1758) varies among 25 to 200 mg L-1. For 
the saltwater species, concentrations among 60 to 75 mg L-1  may be used for the Atlantic 
cod Gadus morhua (Linnaeus, 1758), in the red seabream Pagrus major (Temminck & 
Schlegel, 1843) works between 50 to 100 mg L-1 and  for the Atlantic halibut Hippoglossus 
hippoglossus (Linnaeus, 1758) it is among 250 to 480 mg L-1 (Popovic et al., 2012).  
For the 2-phenoxyethanol the effective dose to achieve deep anaesthesia varies between 
60 and 900 mg L-1 (Priborsky & Velisek, 2018). This range of effective concentrations also 
includes freshwater and saltwater species and also different sizes of fish. For freshwater 
species such as common carp C.carpio this range is among 400 to 600 mg L-1, for tench T. 
tinca it works between 100 to 500 mg L-1 and the concentration 900 mg L-1 was better for 
bighead carp Hypophthalmichthys nobilis (Richardson, 1845). For the saltwater species, it 
were referred the concentrations between 60 to 200 mg L−1 for gilt-head sea bream S. 
auratus, among 200 to 300 mg L-1  for the black sea bass Centropristis striata (Linnaeus, 
1758) and 350 mg L-1 for the European sea bass D. labrax . 
The study by Hoskonen & Pirhonen, (2004) demonstrated that amplitude of the ideal dose 
of clove oil was a result from different actions of eugenol, for each species of fish, for Atlantic 
salmon Salmo salar  Linnaeus, 1758, brown trout Salmo trutta Linnaeus, 1758, rainbow 
trout (O. mykiss), whitefish Coregonus lavaretus Linnaeus, 1758, perch Perca fluviatilis 
Linnaeus, 1758, and roach Rutilus rutilus Linnaeus, 1758, so, the effective dose of to 
achieve deep anaesthesia varies between 20 and 120 mg L-1 (Ross & Ross, 2008) but this 
range can be amplified up to the 150 mg L-1 (Perdikaris et al., 2010). 
Perdikaris et al. (2010, Table VII) used three concentrations of clove oil (75, 100 and  
150 mg L-1) in three size classes of the goldfish C. auratus (1.5 - 2.5 cm; 5 - 7cm; 11 - 15 
cm and 20 - 25 cm) at 18 °C. They found that the higher the concentration, the shorter the 
induction time for the size classes until 15 cm. The same situation happened for the 
recovery time, as mentioned by Mylonas et al. (2005; Table VII). For size class 20 to 25 cm, 
C. auratus presented a longer induction time inversely related to the anaesthetic 
concentration. These authors also assessed the same clove oil concentrations in two size 
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classes of rainbow trout O. mykiss (20 - 23 cm and 30 - 33 cm, Table VII) at 12 °C. The 
both also took longer to be induced at higher anaesthetic doses. These three last 
observations contradicted those of Park et al. (2008), but all did in fact take longer to 
recover, in which the goldfish was faster than the rainbow trout. 
On the other hand, Yildiz et al. (2013, Table VII) observed that the rainbow trout’s (15.48 
and 39.08 g) induction times for 2-phenoxyethanol (200 to 600 mg L-1) and clove oil (500 to 
1500 mg L-1) decreased with increasing concentrations, while the recovery time for both 
anaesthetics increased. The results were according to Park et al., (2008), despite the 
different temperatures used (7, 13 and 18 °C), but contradict the results obtained by 
Perdikaris et al., (2010) for the same species. 
Another study using goldfish C. auratus (2.4 cm and 23 g) assessed the influence of water 
salinity (0, 8, 12, 14 and 16) at 25.6 °C on the anaesthesia dose with MS-222 (150 to  
500 mg L-1). Küçük & Çoban, (2016) demonstrated that the induction time decreased with 
the MS-222 concentrations augmentation, which agrees with the studies of Park et al. 
(2008) and Yildiz et al. (2013). However, there was an inverse relationship between the 
recovering time and MS-222 concentration, contradicting those authors and supporting the 
findings of by Mylonas et al. (2005) and Perdikaris et al. (2010). Furthermore, as freshwater 
fish, C. auratus revealed increased anaesthesia induction and reduced recovery times with 
the incremetation of water salinity (Küçük & Çoban, (2016). Anaesthetics MS-222, 2-
phenoxyethanol and clove oil were used for marine fish (Table VII), such as European sea 
bass D. labrax and the gilthead sea bream S. aurata (Mylonas et al., 2005), Senegalese 
sole S. senegalensis (Weber et al., 2009), Atlantic halibut H.hippoglossus (Zahl et al., 
2011), marbled spinefoot Siganus rivulatus Forsskål & Niebuhr, 1775 (Ghanawi et al., 
2013), Persian sturgeon Acipenser persicus Borodin, 1897 (Adel et al., 2016) and meagre 
Argyrosomus regius (Asso, 1801) (Barata et al., 2016). Generally, marine fish are 
anaesthetised with lower concentrations of the same anaesthetic agent than related fresh 
water species (Table VII). Such empirical observation may be related to the fact that marine 
fish need to copious drink seawater to avoid dehydration and excessive ion in their tissues 
This behaviour results from the fact that they live in a hyperosmotic environment and 
therefore, need to compensate the osmotic loss of water into the surroundings. So, they will 
absorb the ingested water into their circulatory system, along with other ions (Watanabe & 
Takei, 2012). Consequentely, they will also probably absorb the anaesthetic agent 
dissolved in the water through the intestine, turning the anaesthesia induction more effective 
than in freshwater fish. Moreover, the excessive ions (as sodium and chloride) are excreted 
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by the gills (Watanabe & Takei, 2012), the common pathway for inhalation anaesthetics as 
MS-222, 2-phenoxyethanol and clove oil. 
So, it can be concluded that the animals reaction to an anaesthetic agent can differ 
according to the environmental conditions, such as temperature, pH, nitrogenous 
compounds and salinity, but also on the species specific constraints (physiology, 
metabolism, integument, body composition, gill and body size), growth rate, sexual maturity 
and stage of the life cycle (Neiffer & Stamper, 2009; Zahl et al., 2011). It was mentioned 
before that the variations in induction time may be due to the absorption rate of anaesthetics 
by inhalation, which is influenced by the ventilation frequency, blood flow and permeability 
of the gills. Increasing water temperatures may potentiate absorption by accelerating 
ventilation frequency, as a response to the increasing metabolic rate resulting from the 
induced stress situation. What is more, warm-water fish are known for having higher 
metabolic rates, plus physiological respiratory adaptations to compensate the lower 
dissolved oxygen in the water column, than cold-water fish. Once in the gills and blood 
stream, the fish will slow down opercular movements and metabolism, which will extend the 
time for clearing the anaesthetic fom the bloodstream. As more anaesthethic is absorbed 
during the induction period, the longer it will take for the fish to recover, after being placed 
in a tank with clean water (Stehly & Gingerich, 1999; Prince & Powell, 2000; Zahl et al., 
2011). This trend was apparent in the present work for G. rufa anaesthetised with MS-222 
and 2-phenoxyethanol (although without a strong statistical support), but not for clove oil.  
Furthermore, other factors may be taken into account. For instance, anaesthesia 
effectiveness may be related to the gill area – body mass ratio. Generally, large fish have a 
smaller gill area in relation to body mass than small fish and therefore, they have a smaller 
area for diffusion. So, large fish usually require a greater concentration of anaesthetic than 
small ones (Coyle et al., 2004; Zahl et al., 2011, 2012). This observation is also supported 
by the physiological evidences in which the basal metabolic rate is lower in large fish than 
in small ones, and hence their oxygen consumption and anaesthetic absorption rates as 
well (Zahl et al., 2011). But there are reported cases in which large fish are easier to 
anaesthetise. As female towards males, large individuals have normally more adipose 
tissue than small ones. So, anaesthesia may occur faster and last longer in this individuals, 
as many anaesthetic agents are liposoluble (e. g. MS-222 and clove oil). The recovery may 
also be slower, as the agent needs to be removed from the fat tissues (Coyle et al., 2004). 
In fact, the present work verified that G. rufa anaesthesia with MS-222 was more effective 
with lower concentrations in small individuals, thus larger concentrations should be used in 
larger fish. In the case of 2-phenoxyethanol, it was the other way around. The small and  
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medium fish should be anaesthetised with a higher dose than the large ones, although 
within a small margin of 75 mg L-1. Anaesthesia with clove oil produced similar results, 
regardless the body size of G. rufa. 
In this work, it was possible to divide the anaesthesia phase in just three stages: impaired 
motion, buoyancy loss and cease of opercular movements. This sequence of events was 
consistent for every single fish, independently of the anaesthetic used, or even itds dosage. 
The description is usally similar in other authors (Coyle et al., 2004), but there are those 
who described other steps that include a normal initial state to an excitatory phase, ending 
with the loss of reflexive movements, which in G. rufa was coincident with the cease of 
opercular movements (Summerfelt & Smith, 1990; Burka et al., 1997; Zahl et al. 2011 
Akinrotimi et al., 2015, Table I). So, different fish species may present different behavioural 
signs and symptoms towards anaesthesia that should be described. Aydin et al. (2019) 
adopted for G. rufa a classification proposed for rainbow trout O. mykiss (Keene et al., 1998) 
and guppy P. reticulata (Cunha et al., 2015). They describe a first induction stage of 
relaxation and unresponsive to stimuli and a final stage in which the loss of buoyancy 
coincides with the absence of opercular movements. However, Aydin et al. (2019) do not 
describe the use of aeration in the immersion recipient, which could explain their incoherent 
classification regarding the behaviour observed during the experimental procedures of this 
work and the ones described by Ferreira et al. (2015a,b, 2016). In fact, G. rufa vigorously 
tried to escape from the recipient as soon as their were immersed in the anaesthetic 
solution. For this reason, it is advisable to use use barriers to prevent that situation. Also, 
the duration of each stage might bring some additional information to understand the 
anaesthetic effects and fish behavioural responses. However, these parameters are 
seldomly referred. Accordingly, the cease of opercular movements was the longest 
induction stage, followed almost equally by the other two stages, both for MS-222 and 2-
phenoxyethanol. But for clove oil, the buoyancy loss was the shortest stage to attain, 
followed by motion impairment and cease of opercular movements was by far the longest 
one. 
In what concerns the anaesthesia recovery phase for G. rufa, it was possible to time four 
stages: initiation of opercular movements, then body movements, buoyancy control and 
normal swimming behaviour. G. rufa generally followed this sequence, regardless of the 
anaesthetic agent that was used. But, in this case there few exceptions in each some of the 
intermediate stages were commuted. The first and last stages were consensual with others 
studies (Coyle et al., 2004), but intermediate stages and their sequence may vary between 
species, individuals and anaesthetic agent. Cunha et al. (2015) considered just three stages 
for the anaesthesia recovery of guppy P. reticulata, combining both the initiation of opercular 
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and body movements into the first stage. Aidyn et al. (2019) considered recovery phase as 
a whole moment, without differentiating stages in it. Generally, the initiation of G. rufa’s 
opercular movements and the normal swimming behaviour were the longest recovery 
stages for both MS-222 and 2-phenoxyethanol, followed by the initiation of body 
movements. The buoyancy control was the shortest one, being frequently simultaneous 
with the initiation of body movements. The clove oil anaesthesia recovery differed by G. rufa 
rapidly regaining opercular movements, shortly after being introduced in clear water, plus 
the much longer time needed to restart behaving normally. Similarly to the induction phase, 
a physical barrier (as a lid) should be used in the recovery container, after the fish starts to 
swim normally, as to prevent its escape. 
Having this reservations in mind, it was notable that the most effective MS-222 
concentrations in G. rufa’s anaesthesia were usally much higher than the ones 
recommended for other warm-water species with similar size, most of them also used in the 
ornamental aquarium trade (Table VII). Among those other species are: the green swordtail 
Xiphophorus helleri Heckel, 1848 (Chambel et al., 2013), the zebra fish Danio rerio 
(Hamilton, 1822) (Chambel et al., 2013), the angelfish Pterophyllum scalare (Lichtenstein, 
1823) (Mitjana et al., 2014), the discus Symphysodon discus Heckel, 1840 (Chambel et al., 
2013) and the guppy Poecilia reticulata Peters, 1859 (Chambel et al., 2013; Mitjana et al., 
2018). But also in relation to other cyprinid fish that can grow much larger than G. rufa, as: 
the Koi carp C. carpio (Bailey et al., 2013) and the goldfish C. auratus (Küçük & Çoban, 
2016). Notwithstanding, the results obtained were slightly lower than those appointed by 
Ferreira et al. (2015a) at 20 °C. 
Likewise, the clove oil concentrations required to anesthetise G. rufa in this study were 
similar to those appointed before by Ferreira et al. (2016), plus the ones recommended for 
the guppy P. reticulata by Cunha et al. (2015) and the goldfish C. auratus (Perdikaris et al., 
2010). Also, they were much higher than those advised by Aydin et al. (2019) for G. rufa 
and others in similar conditions (Table VII), as: the Southern platyfish  
Xiphophorus maculatus (Günther, 1866) (Küçük & Çoban, 2016), the angelfish P. scalare 
(Mitjana et al., 2014), the guppy P. reticulata by Mitjana et al. (2018). But also in relation to 
those cyprinids able to attain larger dimensions, as the common carp C. carpio (Hajek et 
al., 2006). 
A different trend was observed with 2-phenoxyethanol. The results obtained in this assay 
were indeed higher than others with those same species, namely of Aydin et al. (2019) also 
with G. rufa, as well as the goldfish C. auratus (Weyl et al., 1996). Moreover, they were also 
bellow those brought forward by Ferreira et al. (2015b) at 20 °C. Yet, most other ornamental 
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species were also effectively anaesthetised with similar doses of 2-phenoxyethanol, 
including: the he angelfish P. scalare (Mitjana et al., 2014), the guppy P. reticulata (Mitjana 
et al., 2018), the bighead carp Hypophthalmichthys nobilis (Richardson, 1845) (Akbary et 
al., 2016) and the silver carp Hypophthalmichthys molitrix (Valenciennes, 1844) (Hedayati, 
2018). 
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5. Conclusion  
This trial showed that Garra rufa can successfully withstand anaesthesia with MS-222, 2-
phenoxyethanol and clove oil at a temperature of 29 °C. The fish recovered fast and well, 
without visible sequels. All fish were males and presented appetence for food after 
anaesthesia, ingesting the total daily dose of feed recommended (corresponding to an ad 
libitum situation; Catarino et al., 2019). Regarding the induction, monitoring and recovery 
times, they varied according to the anaesthetic, concentration and fish size class. In the 
induction and recovery times of the three anaesthesics it was not possible to establish a 
relationship between them in this concentrations. But in other studies, it is generally verified 
that the higher the concentration of anaesthetic used, the shorter was the induction time 
and conversely, the longer was the recovery time. Of the three anaesthetics used, clove oil 
was the one with the longest induction and recovery times. Afterwards, MS-222 and 2-
phenoxyethanol presented similar times. Based on all results obtained during this study, it 
was also possible to find out which concentrations were most effective for each G. rufa’s 
size class and each anaesthetic. For the anaesthetic MS-222 the concentration of 300  
mg L-1 should be used in small fish (4.31 ± 0.42 cm and 0.86 ± 0.70 g) whilst for the medium 
fish (6.46 ± 0.85 cm and 3.20 ± 1.62 g) should be 350 mg L-1 and 375 mg L-1 for the large 
size fish (9.42 ± 0.70 cm and 9.74 ± 1.97 g). While in 2-phenoxyethanol the concentration 
should be used for the small (4.53 ± 0.32 cm and 0.75 ± 0.26 g) and medium fish (6.44 ± 
0.90 cm and 3.29 ± 1.62 g) is 825 mg L-1 but on the other hand for the large fish (9.30 ± 
0.67 cm and 10.0 ± 2.06 g) the recommended concentration is 750 mg L-1. Likewise, the 
recommended dose of clove oil for G. rufa is 130 mg L-1 for all size classes (4.41 ± 0.26 cm 
and 0.69 ± 0.19 g for the small, 6.48 ± 0.89 cm and 3.15 ± 1.36 g for the medium and 9.43 
± 0.54 cm and 9.86 ± 1.84 g for the large). These concentrations are those recommended 
for the temperature of 29° C. 
It can be concluded that the anaesthetics MS-222, 2-phenoxyethanol and clove oil are 
effective for Garra rufa routine handling procedures and physical assessment, regardless 
of the fish size class. They were able to produce deep anaesthesia, without causing noticible 
physical damages or affecting fish welfare. 
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6. Future perspectives 
There is not much information/studies in the literature regarding Garra rufa. So, further 
studies on the life cycle, growth, feeding, reproduction and pathologies would be a good 
option and important for their maintenance in captivity, independently of its purpose (animal 
animal science, aquaculture, aquarium trade, spa and therapeutic industry). In the specific 
case of this study, namely at the level of anaesthesia, it would also be important to test 
different temperatures, other anaesthetics, concentration levels and size classes. Studies 
in embryos, larvae and juveniles would also be relevant as anaesthesia research is mainly 
performed in adult fish. 
In addition, to animal behaviour when anaesthetised, physiological responses, 
hematological and histopathological surveys would be a very good complement to better 
understand health consequences of repeated anaesthesia procedures, in the scope of 
animal husbandry and welfare, as well as response to stress and disease situations. The 
resulting information would contribute to establish regulatory constraints on the use of 
anaesthetics, elaborate standard protocols and anticipate factor interdependencies 
impacting the specific efficacy of anaesthesia (Popovic et al., 2012). All the information 
would be instrumental in ameliorating the rearing conditions of this species and the 
veterinary health support. 
Ichthyotherapy studies are also necessary, since this G. rufa is widely used in spas around 
the world for skin treatments. These would help extending the knowledge on the interaction 
between humans and these fish, which is also important both for human health and G. rufa’s 
ecological conservation status. 
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